                               SEQUENCE LISTING

<110> SHANGHAI XBH BIOTECHNOLOGY CO., LTD.
 
<120> COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND
      CANCERS BY TARGETING IGSF8

<130> 134325-00320

<140> PCT/CN2021/111469
<141> 2021-08-09

<150> PCT/CN2020/108129
<151> 2020-08-10

<160> 826   

<170> PatentIn version 3.5

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Arg Tyr Arg Met Ser 
1               5   


<210> 2
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Arg Ile Ser Arg Ser Gly Gly Ala Thr Ala Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 4
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Arg Ala Ser Gln Thr Ile Thr Arg His Leu Asn 
1               5                   10      


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 5
Gly Thr Ser Ala Leu Gln Thr 
1               5           


<210> 6
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 6
Gln Gln Ser His Thr Lys Pro Trp Thr 
1               5                   


<210> 7
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 7
Gln Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 8
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 9
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 9
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 10
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 11
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Glu Ile Ala Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 12
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile His 
1               5                   10                  15  


<210> 13
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 13
Gly Val Pro Pro Arg Phe Ser Gly Gly Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Asn Ser Leu Gln Pro Glu Asp Phe Gly Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 14
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Phe Gly Pro Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 15
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 15
Gln Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Ser Arg Ser Gly Gly Ala Thr Ala Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210> 16
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 16
Glu Ile Ala Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Thr Arg His 
            20                  25                  30          


Leu Asn Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


His Gly Thr Ser Ala Leu Gln Thr Gly Val Pro Pro Arg Phe Ser Gly 
    50                  55                  60                  


Gly Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Thr Tyr Tyr Cys Gln Gln Ser His Thr Lys Pro Trp 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 17
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 17
Ser Tyr Pro Met Asn 
1               5   


<210> 18
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Arg Ile Ser Arg Ser Gly Gly Arg Thr Ser Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 19
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Asp Ala Thr Arg Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 20
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 20
Arg Ala Ser Arg Ser Val Gly Lys Tyr Leu Ala 
1               5                   10      


<210> 21
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 21
Tyr Ala Ser Leu Arg Ala Gly 
1               5           


<210> 22
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 22
Gln Gln Tyr Gly Ser Ser Pro Arg Thr 
1               5                   


<210> 23
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 23
Glu Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 24
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 24
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 25
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 25
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 26
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 26
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 27
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 27
Asp Val Val Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys 
            20              


<210> 28
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 28
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe Tyr 
1               5                   10                  15  


<210> 29
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 29
Asp Ile Pro Ser Arg Phe Thr Ala Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 30
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 30
Phe Gly Gln Gly Thr Lys Leu Glu Met Lys Arg Thr Val 
1               5                   10              


<210> 31
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 31
Glu Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Pro Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Ser Arg Ser Gly Gly Arg Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Arg Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210> 32
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 32
Asp Val Val Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys Arg Ala Ser Arg Ser Val Gly Lys Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe 
        35                  40                  45              


Tyr Tyr Ala Ser Leu Arg Ala Gly Asp Ile Pro Ser Arg Phe Thr Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Met Lys Arg Thr Val 
            100                 105                 110 


<210> 33
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 33
His Tyr Pro Met Arg 
1               5   


<210> 34
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 34
Ser Ile Arg Arg Ser Gly Gly Arg Thr Lys Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 35
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 35
Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 36
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 36
Arg Thr Ser Gln Val Ile Gly Thr Ser Leu Asn 
1               5                   10      


<210> 37
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 37
Ser Ala Ser Asn Leu Gln Ser 
1               5           


<210> 38
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 38
Gln Gln Ser Ser Arg Val Pro His Thr 
1               5                   


<210> 39
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 39
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 40
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 40
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 41
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 41
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 42
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 42
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 43
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 43
Asp Val Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 44
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 44
Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 45
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 45
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly His Gly Thr Gln Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Ser Cys 
            20                  25                  30          


<210> 46
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 46
Phe Gly Gln Gly Thr Lys Leu Glu Met Arg Arg Thr Val 
1               5                   10              


<210> 47
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 47
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser His Tyr 
            20                  25                  30          


Pro Met Arg Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Arg Arg Ser Gly Gly Arg Thr Lys Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210> 48
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 48
Asp Val Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Thr Ser Gln Val Ile Gly Thr Ser 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Asn Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly His Gly Thr Gln Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Ser Ser Arg Val Pro His 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Met Arg Arg Thr Val 
            100                 105                 110 


<210> 49
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 49
Arg Tyr Arg Met Gly 
1               5   


<210> 50
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 50
Ser Ile Ala Arg Ser Gly Gly Arg Thr Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 51
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 51
Gly Val Arg Tyr Cys Ser Ser Pro Ser Cys Ser Arg Gly Pro Arg Tyr 
1               5                   10                  15      


Ala Met Asp Val 
            20  


<210> 52
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 52
Arg Ala Ser Gln Gly Ile Ser Ser Trp Leu Ala 
1               5                   10      


<210> 53
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 53
Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210> 54
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 54
Gln Gln Ala Asn Ser Phe Pro Ile Thr 
1               5                   


<210> 55
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 55
Gln Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 56
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 56
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 57
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 57
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 58
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 58
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 59
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 59
Glu Ile Val Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 60
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 60
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 61
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 61
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 62
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 62
Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 63
<211> 129
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 63
Gln Val Gln Leu Leu Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Gly Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ala Arg Ser Gly Gly Arg Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Arg Tyr Cys Ser Ser Pro Ser Cys Ser Arg Gly Pro 
            100                 105                 110         


Arg Tyr Ala Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210> 64
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 64
Glu Ile Val Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 65
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 65
Arg Tyr Arg Met Ala 
1               5   


<210> 66
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 66
Asn Ile Thr Arg Ser Gly Gly Val Thr Arg Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 67
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 67
Asp Pro Asn Arg Val Thr Ala Ile Ser Ser His Tyr Gly Met Asp Val 
1               5                   10                  15      


<210> 68
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 68
Arg Ala Ser Gln Ser Ile Ser Arg Trp Leu Ala 
1               5                   10      


<210> 69
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 69
Asp Ala Ser Asn Arg Ala Thr 
1               5           


<210> 70
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 70
Gln Gln Arg Ser Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210> 71
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 71
Glu Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 72
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 72
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 73
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 73
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 74
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 74
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 75
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 75
Glu Ile Val Leu Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys 
            20              


<210> 76
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 76
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 77
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 77
Gly Val Pro Ala Arg Phe Ser Val Ser Gly Ser Glu Thr Asp Ser Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Met Tyr Tyr Cys 
            20                  25                  30          


<210> 78
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 78
Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 79
<211> 125
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 79
Glu Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Asn Ile Thr Arg Ser Gly Gly Val Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Asn Arg Val Thr Ala Ile Ser Ser His Tyr Gly Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210> 80
<211> 112
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 80
Glu Ile Val Leu Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Gln Ser Ile Ser Arg Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Val Pro Ala Arg Phe Ser Val 
    50                  55                  60                  


Ser Gly Ser Glu Thr Asp Ser Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Met Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110         


<210> 81
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 81
Pro Tyr Arg Met His 
1               5   


<210> 82
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 82
Arg Ile Asn Pro Ser Gly Gly Arg Thr Trp Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 83
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 83
Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 84
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 84
Arg Ala Ser Gln Ser Ile Asn Lys Trp Leu Ala 
1               5                   10      


<210> 85
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 85
Lys Ala Ser Thr Leu Glu Ser 
1               5           


<210> 86
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 86
Gln Gln Ser His Ser Ala Pro Trp Thr 
1               5                   


<210> 87
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 87
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 88
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 88
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 89
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 89
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 90
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 90
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
1               5                   10      


<210> 91
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 91
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 92
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 92
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 93
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 93
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Asn Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 94
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 94
Phe Gly Gln Gly Thr Lys Val Glu Ile Glu Arg Thr Val 
1               5                   10              


<210> 95
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 95
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Pro Tyr 
            20                  25                  30          


Arg Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Asn Pro Ser Gly Gly Arg Thr Trp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120     


<210> 96
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 96
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Asn Lys Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Thr Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser His Ser Ala Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Glu Arg Thr Val 
            100                 105                 110 


<210> 97
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 97
Ser Tyr Pro Met Asn 
1               5   


<210> 98
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 98
Arg Ile Ser Arg Ser Gly Gly Arg Thr Ser Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 99
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 99
Asp Ala Thr Arg Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 100
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 100
Arg Ala Ser Arg Ser Val Gly Lys Tyr Leu Ala 
1               5                   10      


<210> 101
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 101
Tyr Ala Ser Leu Arg Ala Gly 
1               5           


<210> 102
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 102
Gln Gln Tyr Gly Ser Ser Pro Arg Thr 
1               5                   


<210> 103
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 103
Glu Val Gln Leu Glu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 104
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 104
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 105
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 105
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 106
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 106
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 107
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 107
Glu Thr Thr Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys 
            20              


<210> 108
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 108
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe Tyr 
1               5                   10                  15  


<210> 109
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 109
Asp Ile Pro Ser Arg Phe Thr Ala Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 110
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 110
Phe Gly Gln Gly Thr Lys Leu Glu Met Lys Arg Thr Val 
1               5                   10              


<210> 111
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 111
Glu Val Gln Leu Glu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Pro Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Ser Arg Ser Gly Gly Arg Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Arg Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210> 112
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 112
Glu Thr Thr Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys Arg Ala Ser Arg Ser Val Gly Lys Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe 
        35                  40                  45              


Tyr Tyr Ala Ser Leu Arg Ala Gly Asp Ile Pro Ser Arg Phe Thr Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Met Lys Arg Thr Val 
            100                 105                 110 


<210> 113
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 113
Ser Tyr Ala Met Ser 
1               5   


<210> 114
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 114
Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 115
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 115
Pro Tyr Asn Ser Ala Trp Glu Ser Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15  


<210> 116
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 116
Arg Ala Ser Gln Gly Ile Ser Ser Arg Leu Ala 
1               5                   10      


<210> 117
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 117
Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210> 118
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 118
Gln Gln Arg His Ser Tyr Pro Ile Thr 
1               5                   


<210> 119
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 119
Glu Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 120
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 120
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 121
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 121
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 122
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 122
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 123
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 123
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 124
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 124
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 125
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 125
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 126
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 126
Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 127
<211> 124
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 127
Glu Val Gln Leu Gln Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Tyr Asn Ser Ala Trp Glu Ser Tyr Tyr Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210> 128
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 128
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Arg 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Arg His Ser Tyr Pro Ile 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 129
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 129
Arg Tyr Asp Met Ser 
1               5   


<210> 130
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 130
Arg Ile Arg Tyr Ser Gly Gly Arg Thr Gly Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 131
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 131
Gly Val Arg Tyr Cys Ser Ser Pro Ser Cys Ser Arg Gly Pro Arg Tyr 
1               5                   10                  15      


Ala Met Asp Val 
            20  


<210> 132
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 132
Arg Ala Ser Gln Ser Val Arg Gly Tyr Leu Ala 
1               5                   10      


<210> 133
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 133
Asp Thr Phe Lys Arg Ala Thr 
1               5           


<210> 134
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 134
Gln Gln Tyr Phe Ala Ser Pro Trp Thr 
1               5                   


<210> 135
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 135
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 136
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 136
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 137
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 137
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 138
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 138
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 139
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 139
Asp Val Val Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Gly Ala Thr Leu Ser Cys 
            20              


<210> 140
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 140
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 141
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 141
Gly Ile Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Ala Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Ser Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 142
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 142
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 143
<211> 129
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 143
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Asp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Arg Tyr Ser Gly Gly Arg Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Arg Tyr Cys Ser Ser Pro Ser Cys Ser Arg Gly Pro 
            100                 105                 110         


Arg Tyr Ala Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210> 144
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 144
Asp Val Val Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Gly Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Arg Gly Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Thr Phe Lys Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Ala Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln Tyr Phe Ala Ser Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 145
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 145
Arg Tyr Arg Met Tyr 
1               5   


<210> 146
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 146
Thr Ile Ser Arg Ser Gly Gly Arg Thr Val Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 147
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 147
Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 148
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 148
Arg Ala Ser Gln Ser Val Ser Ser Asn Val Ala 
1               5                   10      


<210> 149
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 149
Gly Ser Gly Thr Arg Ala Thr 
1               5           


<210> 150
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 150
Gln Gln Tyr Asn Asp Trp Pro Ser 
1               5               


<210> 151
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 151
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 152
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 152
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 153
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 153
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 154
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 154
Trp Gly Gln Gly Thr Leu Val Thr Val 
1               5                   


<210> 155
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 155
Glu Thr Thr Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 156
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 156
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Met Phe 
1               5                   10                  15  


<210> 157
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 157
Gly Ile Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Glu Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Ser Glu Asp Phe Ala Ala Tyr Tyr Cys 
            20                  25                  30          


<210> 158
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 158
Phe Gly Gln Gly Thr Arg Val Glu Ile Lys Gly Thr Val 
1               5                   10              


<210> 159
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 159
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Ser Arg Ser Gly Gly Arg Thr Val Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val 
        115                 


<210> 160
<211> 109
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 160
Glu Thr Thr Leu Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Val Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Met 
        35                  40                  45              


Phe Gly Ser Gly Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Ala Tyr Tyr Cys Gln Gln Tyr Asn Asp Trp Pro Ser 
                85                  90                  95      


Phe Gly Gln Gly Thr Arg Val Glu Ile Lys Gly Thr Val 
            100                 105                 


<210> 161
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 161
Arg Tyr Arg Met Tyr 
1               5   


<210> 162
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 162
Ser Ile Ser Ser Ser Gly Gly Arg Thr Lys Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 163
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 163
Gly Val Arg Tyr Cys Ser Ser Pro Ser Cys Ser Arg Gly Pro Arg Tyr 
1               5                   10                  15      


Ala Met Asp Val 
            20  


<210> 164
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 164
Arg Ala Ser Tyr Val Ile Arg Asn Asp Leu Ser 
1               5                   10      


<210> 165
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 165
Gly Thr Ser Ser Leu His Asn 
1               5           


<210> 166
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 166
Leu Gln Asp Asp Lys Tyr Pro Leu Thr 
1               5                   


<210> 167
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 167
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 168
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 168
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 169
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 169
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 170
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 170
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 171
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 171
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 172
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 172
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 173
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 173
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Tyr Gly Thr Tyr Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Gly Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 174
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 174
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 175
<211> 129
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 175
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Gly Gly Arg Thr Lys Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Arg Tyr Cys Ser Ser Pro Ser Cys Ser Arg Gly Pro 
            100                 105                 110         


Arg Tyr Ala Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210> 176
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 176
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Tyr Val Ile Arg Asn Asp 
            20                  25                  30          


Leu Ser Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Thr Ser Ser Leu His Asn Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Tyr Gly Thr Tyr Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Thr Tyr Tyr Cys Leu Gln Asp Asp Lys Tyr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 177
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 177
Lys Tyr Lys Met Ser 
1               5   


<210> 178
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 178
Thr Ile Ala Pro Ser Gly Gly Gly Thr Arg Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 179
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 179
Gly Gly His Phe Ser Asn Pro 
1               5           


<210> 180
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 180
Arg Ser Ser Gln Ser Leu Val His Thr Asp Gly Asp Thr Tyr Leu Asn 
1               5                   10                  15      


<210> 181
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 181
Lys Val Ser Lys Arg Asp Ser 
1               5           


<210> 182
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 182
Met Gln Gly Ile Lys Arg Pro Tyr Thr 
1               5                   


<210> 183
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 183
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 184
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 184
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 185
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 185
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 186
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 186
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 187
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 187
Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys 
            20              


<210> 188
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 188
Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Arg Arg Leu Ile Tyr 
1               5                   10                  15  


<210> 189
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 189
Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys 
            20                  25                  30          


<210> 190
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 190
Leu Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 191
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 191
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Lys Tyr 
            20                  25                  30          


Lys Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Ala Pro Ser Gly Gly Gly Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly His Phe Ser Asn Pro Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210> 192
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 192
Asp Val Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val His Thr 
            20                  25                  30          


Asp Gly Asp Thr Tyr Leu Asn Trp Tyr Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Lys Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Ile Lys Arg Pro Tyr Thr Leu Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Thr Val 
        115 


<210> 193
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 193
Pro Tyr Arg Met His 
1               5   


<210> 194
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 194
Ser Ile Asn Arg Ser Gly Gly Arg Thr Asn Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 195
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 195
Gly Arg Gly Ile Gly Thr Phe Arg Asn 
1               5                   


<210> 196
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 196
Arg Ala Ser Gln Ser Val Ser Thr Tyr Leu Ala 
1               5                   10      


<210> 197
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 197
Asp Ala Ser Asn Arg Ala Thr 
1               5           


<210> 198
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 198
Gln Gln Arg Asn Asn Trp Pro Pro Thr 
1               5                   


<210> 199
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 199
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 200
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 200
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 201
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 201
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Thr 
            20                  25                  30          


<210> 202
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 202
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 203
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 203
Asp Ile Ala Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 204
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 204
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Ser 
1               5                   10                  15  


<210> 205
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 205
Gly Ile Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 206
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 206
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 207
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 207
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Pro Tyr 
            20                  25                  30          


Arg Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Asn Arg Ser Gly Gly Arg Thr Asn Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Gly Arg Gly Ile Gly Thr Phe Arg Asn Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210> 208
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 208
Asp Ile Ala Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Thr Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Ser Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Asn Asn Trp Pro Pro 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 209
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 209
Ser Tyr Ala Met Ser 
1               5   


<210> 210
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 210
Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 211
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 211
Asp Thr Ile Pro Gly Tyr Met Asp Val 
1               5                   


<210> 212
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 212
Arg Ala Ser Gln Ser Ile Ser Asn Tyr Leu Ser 
1               5                   10      


<210> 213
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 213
Ala Ala Ser Ser Leu Gln Ser 
1               5           


<210> 214
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 214
Gln Gln Ser Tyr Ser Ser Pro Tyr Thr 
1               5                   


<210> 215
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 215
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 216
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 216
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 217
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 217
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 218
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 218
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 219
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 219
Asp Ile Met Leu Thr Gln Ser Pro Ser Ser Leu Ser Gly Ser Val Gly 
1               5                   10                  15      


Asp Ser Val Thr Phe Thr Cys 
            20              


<210> 220
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 220
Trp Tyr Gln Gln Lys Ser Gly Lys Ala Pro Gln Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 221
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 221
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 222
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 222
Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 223
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 223
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Thr Ile Pro Gly Tyr Met Asp Val Trp Gly Lys Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210> 224
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 224
Asp Ile Met Leu Thr Gln Ser Pro Ser Ser Leu Ser Gly Ser Val Gly 
1               5                   10                  15      


Asp Ser Val Thr Phe Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ser Trp Tyr Gln Gln Lys Ser Gly Lys Ala Pro Gln Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 225
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 225
Arg Tyr Arg Met Ala 
1               5   


<210> 226
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 226
Ala Ile Ala Arg Ser Gly Gly Arg Thr Trp Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 227
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 227
Gly Gly Gly Ala Lys Trp Leu Tyr Asn Trp Phe Asp Ser 
1               5                   10              


<210> 228
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 228
Arg Ala Ser Gln Ser Val Ser Asn Thr Tyr Leu Ala 
1               5                   10          


<210> 229
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 229
Gly Ala Ser Ile Arg Ala Pro 
1               5           


<210> 230
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 230
Gln Gln Tyr Ala Arg Ser Arg Ile Ala 
1               5                   


<210> 231
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 231
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 232
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 232
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 233
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 233
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 234
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 234
Trp Gly Gln Gly Thr Leu Val Thr Val 
1               5                   


<210> 235
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 235
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Ala Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 236
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 236
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 237
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 237
Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Val Asn Arg Leu Glu Pro Glu Asp Ser Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 238
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 238
Phe Gly Gln Gly Thr Arg Leu Glu Ile Arg Arg Thr Val 
1               5                   10              


<210> 239
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 239
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ala Arg Ser Gly Gly Arg Thr Trp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Gly Ala Lys Trp Leu Tyr Asn Trp Phe Asp Ser Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val 
        115                 120 


<210> 240
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 240
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Ala Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Asn Thr 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ile Arg Ala Pro Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Val Asn Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Ser Ala Val Tyr Tyr Cys Gln Gln Tyr Ala Arg Ser Arg 
                85                  90                  95      


Ile Ala Phe Gly Gln Gly Thr Arg Leu Glu Ile Arg Arg Thr Val 
            100                 105                 110     


<210> 241
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 241
His Tyr Trp Met Gly 
1               5   


<210> 242
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 242
Gly Ile Gly Ala Ser Gly Gly Trp Thr Gly Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 243
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 243
Thr Ser Gly Ala Tyr Phe Asp Tyr 
1               5               


<210> 244
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 244
Arg Ala Ser Gln Ser Val Ser Ser Asp Tyr Leu Ala 
1               5                   10          


<210> 245
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 245
Gly Ala Ser Ser Arg Ala Thr 
1               5           


<210> 246
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 246
Gln Gln Tyr Gly Ser Thr Pro Leu Thr 
1               5                   


<210> 247
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 247
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 248
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 248
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 249
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 249
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 250
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 250
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 251
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 251
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Gln Arg Ala Thr Leu Ser Cys 
            20              


<210> 252
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 252
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Met Tyr 
1               5                   10                  15  


<210> 253
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 253
Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 254
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 254
Phe Gly Gly Gly Thr Thr Val Glu Ile Arg Arg Thr Val 
1               5                   10              


<210> 255
<211> 117
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 255
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser His Tyr 
            20                  25                  30          


Trp Met Gly Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Gly Ala Ser Gly Gly Trp Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser Gly Ala Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210> 256
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 256
Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Gln Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asp 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Met Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Thr Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Thr Val Glu Ile Arg Arg Thr Val 
            100                 105                 110     


<210> 257
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 257
Asn Tyr Pro Met Thr 
1               5   


<210> 258
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 258
Thr Ile Arg Gly Ser Gly Gly Asp Thr Trp Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 259
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 259
Trp Val Gly Arg Asp Ala 
1               5       


<210> 260
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 260
Arg Ser Ser Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr Leu Asn 
1               5                   10                  15      


<210> 261
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 261
Lys Val Ser Asn Arg Asp Ser 
1               5           


<210> 262
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 262
Met Gln Gly Thr His Trp Pro Pro Thr 
1               5                   


<210> 263
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 263
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 264
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 264
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 265
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 265
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Lys 
            20                  25                  30          


<210> 266
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 266
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 267
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 267
Asp Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys 
            20              


<210> 268
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 268
Trp Phe Arg Gln Arg Pro Gly Gln Ser Pro Arg Arg Leu Ile Tyr 
1               5                   10                  15  


<210> 269
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 269
Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Arg Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys 
            20                  25                  30          


<210> 270
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 270
Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 271
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 271
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Pro Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Arg Gly Ser Gly Gly Asp Thr Trp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Trp Val Gly Arg Asp Ala Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210> 272
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 272
Asp Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Arg Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Arg Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Pro Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Thr Val 
        115 


<210> 273
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 273
Ser Tyr Pro Met Asn 
1               5   


<210> 274
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 274
Arg Ile Ser Arg Ser Gly Gly Arg Thr Ser Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 275
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 275
Asp Ala Thr Arg Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 276
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 276
Arg Ala Ser Arg Ser Val Gly Lys Tyr Leu Ala 
1               5                   10      


<210> 277
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 277
Tyr Ala Ser Leu Arg Ala Gly 
1               5           


<210> 278
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 278
Gln Gln Tyr Gly Ser Ser Pro Arg Thr 
1               5                   


<210> 279
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 279
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 280
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 280
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 281
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 281
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 282
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 282
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 283
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 283
Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys 
            20              


<210> 284
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 284
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe Tyr 
1               5                   10                  15  


<210> 285
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 285
Asp Ile Pro Ser Arg Phe Thr Ala Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Arg Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 286
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 286
Phe Gly Gln Gly Thr Lys Leu Glu Met Lys Arg Thr Val 
1               5                   10              


<210> 287
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 287
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Pro Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Ser Arg Ser Gly Gly Arg Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Arg Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210> 288
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 288
Asp Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ser Leu Ser Cys Arg Ala Ser Arg Ser Val Gly Lys Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe 
        35                  40                  45              


Tyr Tyr Ala Ser Leu Arg Ala Gly Asp Ile Pro Ser Arg Phe Thr Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Met Lys Arg Thr Val 
            100                 105                 110 


<210> 289
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 289
Arg Tyr Arg Met His 
1               5   


<210> 290
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 290
Ser Ile Ala Ser Ser Gly Gly Arg Thr Arg Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 291
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 291
Gly Gly Leu Pro Tyr Arg Gly His Tyr Gly Met Asp Val 
1               5                   10              


<210> 292
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 292
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210> 293
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 293
Val Ala Ser Ser Leu Gln Ser 
1               5           


<210> 294
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 294
Gln Gln Ala Arg Ser Ile Pro Trp Thr 
1               5                   


<210> 295
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 295
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 296
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 296
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 297
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 297
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 298
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 298
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 299
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 299
Glu Ile Met Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 300
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 300
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Ser 
1               5                   10                  15  


<210> 301
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 301
Gly Val Pro Ser Arg Phe Ser Gly Ser Arg Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 302
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 302
Phe Gly Gln Gly Thr Asn Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 303
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 303
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ala Ser Ser Gly Gly Arg Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Leu Pro Tyr Arg Gly His Tyr Gly Met Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 304
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 304
Glu Ile Met Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Ser Val Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Arg Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Arg Ser Ile Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Asn Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 305
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 305
Ser Tyr Ala Met Ser 
1               5   


<210> 306
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 306
Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 307
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 307
Gly Gly Leu Pro Tyr Arg Gly His Tyr Gly Met Asp Val 
1               5                   10              


<210> 308
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 308
Arg Ser Ser Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr Val Asp 
1               5                   10                  15      


<210> 309
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 309
Leu Gly Ser Asn Arg Ala Ser 
1               5           


<210> 310
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 310
Met Gln Ala Leu Lys Ile Pro Arg Thr 
1               5                   


<210> 311
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 311
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 312
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 312
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 313
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 313
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 314
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 314
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 315
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 315
Asp Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys 
            20              


<210> 316
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 316
Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Gln Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 317
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 317
Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys 
            20                  25                  30          


<210> 318
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 318
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 319
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 319
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Leu Pro Tyr Arg Gly His Tyr Gly Met Asp Val Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 320
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 320
Asp Ile Val Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Val Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Lys Ile Pro Arg Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


Arg Thr Val 
        115 


<210> 321
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 321
Pro Tyr Tyr Met Val 
1               5   


<210> 322
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 322
Ser Ile Asn Arg Ser Gly Gly Arg Thr Ala Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 323
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 323
Ala Ile Ala Ala Gly Arg Tyr Gly Met Asp Val 
1               5                   10      


<210> 324
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 324
Arg Ala Ser Gln Ser Val Ser Ser Tyr Leu Ala 
1               5                   10      


<210> 325
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 325
Asp Ala Ser Asn Arg Ala Thr 
1               5           


<210> 326
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 326
Gln Gln Arg Thr Asn Trp Pro Pro Leu Thr 
1               5                   10  


<210> 327
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 327
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 328
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 328
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 329
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 329
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 330
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 330
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 331
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 331
Asp Ile Glu Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 332
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 332
Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 333
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 333
Gly Ile Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 334
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 334
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 335
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 335
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Pro Tyr 
            20                  25                  30          


Tyr Met Val Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Asn Arg Ser Gly Gly Arg Thr Ala Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Ile Ala Ala Gly Arg Tyr Gly Met Asp Val Trp Gly Lys 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210> 336
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 336
Asp Ile Glu Met Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Pro Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Thr Asn Trp Pro Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110     


<210> 337
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 337
Arg Tyr Thr Met Arg 
1               5   


<210> 338
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 338
Gly Ile Ser Arg Ser Gly Gly Arg Thr Val Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 339
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 339
Asp Pro Phe Gly Val Val Asn His Phe Tyr Tyr Met Asp Val 
1               5                   10                  


<210> 340
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 340
Arg Ala Ser Gln Ser Ile His Thr Tyr Leu Asn 
1               5                   10      


<210> 341
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 341
Gly Ala Ser Asn Leu Gln Asn 
1               5           


<210> 342
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 342
Gln Gln Thr Tyr Arg Thr Pro Thr Thr 
1               5                   


<210> 343
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 343
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 344
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 344
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 345
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 345
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 346
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 346
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 347
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 347
Glu Ile Met Leu Thr Gln Ser Pro Pro Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 348
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 348
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 349
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 349
Gly Val Pro Ser Arg Phe Ser Gly Thr Gly Ser Gly Thr Asp Phe Ala 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Ser Cys 
            20                  25                  30          


<210> 350
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 350
Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val 
1               5                   10              


<210> 351
<211> 123
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 351
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Thr Met Arg Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Arg Ser Gly Gly Arg Thr Val Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Phe Gly Val Val Asn His Phe Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210> 352
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 352
Glu Ile Met Leu Thr Gln Ser Pro Pro Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile His Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Asn Leu Gln Asn Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ala Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Thr Tyr Arg Thr Pro Thr 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 353
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 353
Ser Tyr Arg Met Ser 
1               5   


<210> 354
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 354
Gly Ile Gly Arg Ser Gly Gly Arg Thr Arg Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 355
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 355
Ala Ile Ala Ala Gly Arg Tyr Gly Met Asp Val 
1               5                   10      


<210> 356
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 356
Arg Ala Ser Gln Ser Ile Arg Asn Asn Tyr Leu Ala 
1               5                   10          


<210> 357
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 357
Gly Ala Ser Tyr Arg Ala Thr 
1               5           


<210> 358
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 358
Gln Gln Arg Ser Asn Trp Pro Pro Thr 
1               5                   


<210> 359
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 359
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 360
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 360
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 361
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 361
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 362
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 362
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 363
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 363
Asp Ile Met Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 364
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 364
Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 365
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 365
Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 366
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 366
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 367
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 367
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Arg Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Gly Arg Ser Gly Gly Arg Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Ile Ala Ala Gly Arg Tyr Gly Met Asp Val Trp Gly Lys 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210> 368
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 368
Asp Ile Met Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Arg Asn Asn 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Tyr Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro 
                85                  90                  95      


Pro Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110     


<210> 369
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 369
Arg Tyr Pro Met Val 
1               5   


<210> 370
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 370
Arg Ile Ser Arg Ser Gly Gly Arg Thr Gln Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 371
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 371
Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val 
1               5                   10          


<210> 372
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 372
Arg Ala Ser Gln Ser Ile Ser Ser Tyr Leu Asn 
1               5                   10      


<210> 373
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 373
Gly Ala Ser Ser Leu Gln Ser 
1               5           


<210> 374
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 374
Gln Gln Ala Asn Ser Phe Pro Leu Thr 
1               5                   


<210> 375
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 375
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 376
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 376
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 377
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 377
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 378
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 378
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 379
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 379
Glu Ile Ala Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 380
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 380
Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 381
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 381
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala Thr Tyr Tyr Cys 
            20                  25                  30          


<210> 382
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 382
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 383
<211> 121
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 383
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Pro Met Val Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Arg Ile Ser Arg Ser Gly Gly Arg Thr Gln Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ala Thr Gly Arg His Tyr Asn Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210> 384
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 384
Glu Ile Ala Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 385
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 385
Ser Tyr Arg Met Ser 
1               5   


<210> 386
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 386
Gly Ile Gly Arg Ser Gly Gly Arg Thr Arg Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 387
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 387
Ala Ile Ala Ala Gly Arg Tyr Gly Met Asp Val 
1               5                   10      


<210> 388
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 388
Arg Ala Ser Gln Ser Ile Arg Asn Asn Tyr Leu Ala 
1               5                   10          


<210> 389
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 389
Gly Ala Ser Tyr Arg Ala Thr 
1               5           


<210> 390
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 390
Gln Gln Arg Ser Asn Trp Pro Pro Thr 
1               5                   


<210> 391
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 391
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 392
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 392
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 393
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 393
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 394
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 394
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 395
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 395
Glu Ile Glu Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 396
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 396
Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 397
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 397
Gly Ile Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 398
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 398
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 399
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 399
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Arg Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Gly Arg Ser Gly Gly Arg Thr Arg Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Ile Ala Ala Gly Arg Tyr Gly Met Asp Val Trp Gly Lys 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210> 400
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 400
Glu Ile Glu Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Ile Arg Asn Asn 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Arg Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Tyr Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro 
                85                  90                  95      


Pro Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110     


<210> 401
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 401
Arg Tyr Arg Met Ala 
1               5   


<210> 402
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 402
Gly Ile Ser Tyr Ser Gly Gly Glu Thr Leu Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 403
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 403
Asp Val Arg Trp Leu Gln Gly Leu Asp Asn 
1               5                   10  


<210> 404
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 404
Arg Ser Ser Gln Ser Leu Leu His Thr Asn Gly Asn Asn Tyr Leu Asp 
1               5                   10                  15      


<210> 405
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 405
Leu Gly Ser Asn Arg Ala Ser 
1               5           


<210> 406
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 406
Met Gln Thr Leu Gln Thr Pro Leu Thr 
1               5                   


<210> 407
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 407
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 408
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 408
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 409
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 409
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 410
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 410
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 411
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 411
Glu Ile Lys Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys 
            20              


<210> 412
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 412
Trp Tyr Leu Gln Lys Pro Gly Gln Ser Pro Gln Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 413
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 413
Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys 
            20                  25                  30          


<210> 414
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 414
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 415
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 415
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg Tyr 
            20                  25                  30          


Arg Met Ala Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Tyr Ser Gly Gly Glu Thr Leu Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Val Arg Trp Leu Gln Gly Leu Asp Asn Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210> 416
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 416
Glu Ile Lys Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Thr 
            20                  25                  30          


Asn Gly Asn Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Thr 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


Arg Thr Val 
        115 


<210> 417
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 417
Ser Tyr Ala Met Ser 
1               5   


<210> 418
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 418
Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 419
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 419
Glu Gly Arg Pro Gly Tyr Met Asp Val 
1               5                   


<210> 420
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 420
Arg Thr Ser Leu Ser Ile Ala Thr Tyr Leu His 
1               5                   10      


<210> 421
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 421
His Ala Ser Ser Leu Gln Thr 
1               5           


<210> 422
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 422
Gln Gln Ser Tyr Ser Ser Pro Tyr Thr 
1               5                   


<210> 423
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 423
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 424
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 424
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 425
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 425
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 426
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 426
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 427
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 427
Glu Ile Val Leu Thr Gln Ser Pro Ser Leu Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys 
            20              


<210> 428
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 428
Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 429
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 429
Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Leu Pro Glu Asp Phe Ala Thr Tyr Phe Cys 
            20                  25                  30          


<210> 430
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 430
Phe Gly Arg Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 431
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 431
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Arg Pro Gly Tyr Met Asp Val Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210> 432
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 432
Glu Ile Val Leu Thr Gln Ser Pro Ser Leu Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Thr Ser Leu Ser Ile Ala Thr Tyr 
            20                  25                  30          


Leu His Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr His Ala Ser Ser Leu Gln Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Leu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Phe Cys Gln Gln Ser Tyr Ser Ser Pro Tyr 
                85                  90                  95      


Thr Phe Gly Arg Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 433
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 433
Val Tyr Gly Met Ile 
1               5   


<210> 434
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 434
Gly Ile Pro Pro Ser Gly Gly Val Thr Leu Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 435
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 435
Gly Asn Tyr Gly Met Asp Val 
1               5           


<210> 436
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 436
Arg Ala Ser Gln Ser Val Ser Ser Tyr Leu Ala 
1               5                   10      


<210> 437
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 437
Asp Ala Ser Asn Arg Ala Thr 
1               5           


<210> 438
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 438
Gln Gln Arg Ser Asn Trp Pro Pro Thr 
1               5                   


<210> 439
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 439
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 440
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 440
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 441
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 441
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Arg 
            20                  25                  30          


<210> 442
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 442
Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10      


<210> 443
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 443
Glu Ile Ala Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys 
            20              


<210> 444
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 444
Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile Tyr 
1               5                   10                  15  


<210> 445
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 445
Gly Ile Pro Ala Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr 
1               5                   10                  15      


Leu Thr Ile Ser Ser Leu Glu Pro Glu Asp Phe Ala Val Tyr Tyr Cys 
            20                  25                  30          


<210> 446
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 446
Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 447
<211> 116
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 447
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Val Tyr 
            20                  25                  30          


Gly Met Ile Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Pro Pro Ser Gly Gly Val Thr Leu Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Asn Tyr Gly Met Asp Val Trp Gly Lys Gly Thr Thr Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210> 448
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 448
Glu Ile Ala Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 449

<400> 449
000


<210> 450

<400> 450
000


<210> 451

<400> 451
000


<210> 452

<400> 452
000


<210> 453

<400> 453
000


<210> 454

<400> 454
000


<210> 455

<400> 455
000


<210> 456

<400> 456
000


<210> 457

<400> 457
000


<210> 458

<400> 458
000


<210> 459

<400> 459
000


<210> 460

<400> 460
000


<210> 461

<400> 461
000


<210> 462

<400> 462
000


<210> 463

<400> 463
000


<210> 464

<400> 464
000


<210> 465
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 465
Met His Ser Ser Ala Leu Leu Cys Cys Leu Val Leu Leu Thr Gly Val 
1               5                   10                  15      


Arg Ala 
        


<210> 466
<211> 104
<212> PRT
<213> Homo sapiens

<400> 466
Ala Ala Pro Ser Val Phe Ile Phe Pro Pro Ser Asp Glu Gln Leu Lys 
1               5                   10                  15      


Ser Gly Thr Ala Ser Val Val Cys Leu Leu Asn Asn Phe Tyr Pro Arg 
            20                  25                  30          


Glu Ala Lys Val Gln Trp Lys Val Asp Asn Ala Leu Gln Ser Gly Asn 
        35                  40                  45              


Ser Gln Glu Ser Val Thr Glu Gln Asp Ser Lys Asp Ser Thr Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Thr Leu Thr Leu Ser Lys Ala Asp Tyr Glu Lys His Lys 
65                  70                  75                  80  


Val Tyr Ala Cys Glu Val Thr His Gln Gly Leu Ser Ser Pro Val Thr 
                85                  90                  95      


Lys Ser Phe Asn Arg Gly Glu Cys 
            100                 


<210> 467
<211> 330
<212> PRT
<213> Homo sapiens

<400> 467
Ala Ser Thr Lys Gly Pro Ser Val Phe Pro Leu Ala Pro Ser Ser Lys 
1               5                   10                  15      


Ser Thr Ser Gly Gly Thr Ala Ala Leu Gly Cys Leu Val Lys Asp Tyr 
            20                  25                  30          


Phe Pro Glu Pro Val Thr Val Ser Trp Asn Ser Gly Ala Leu Thr Ser 
        35                  40                  45              


Gly Val His Thr Phe Pro Ala Val Leu Gln Ser Ser Gly Leu Tyr Ser 
    50                  55                  60                  


Leu Ser Ser Val Val Thr Val Pro Ser Ser Ser Leu Gly Thr Gln Thr 
65                  70                  75                  80  


Tyr Ile Cys Asn Val Asn His Lys Pro Ser Asn Thr Lys Val Asp Lys 
                85                  90                  95      


Lys Val Glu Pro Lys Ser Cys Asp Lys Thr His Thr Cys Pro Pro Cys 
            100                 105                 110         


Pro Ala Pro Glu Leu Leu Gly Gly Pro Ser Val Phe Leu Phe Pro Pro 
        115                 120                 125             


Lys Pro Lys Asp Thr Leu Met Ile Ser Arg Thr Pro Glu Val Thr Cys 
    130                 135                 140                 


Val Val Val Asp Val Ser His Glu Asp Pro Glu Val Lys Phe Asn Trp 
145                 150                 155                 160 


Tyr Val Asp Gly Val Glu Val His Asn Ala Lys Thr Lys Pro Arg Glu 
                165                 170                 175     


Glu Gln Tyr Asn Ser Thr Tyr Arg Val Val Ser Val Leu Thr Val Leu 
            180                 185                 190         


His Gln Asp Trp Leu Asn Gly Lys Glu Tyr Lys Cys Lys Val Ser Asn 
        195                 200                 205             


Lys Ala Leu Pro Ala Pro Ile Glu Lys Thr Ile Ser Lys Ala Lys Gly 
    210                 215                 220                 


Gln Pro Arg Glu Pro Gln Val Tyr Thr Leu Pro Pro Ser Arg Asp Glu 
225                 230                 235                 240 


Leu Thr Lys Asn Gln Val Ser Leu Thr Cys Leu Val Lys Gly Phe Tyr 
                245                 250                 255     


Pro Ser Asp Ile Ala Val Glu Trp Glu Ser Asn Gly Gln Pro Glu Asn 
            260                 265                 270         


Asn Tyr Lys Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe 
        275                 280                 285             


Leu Tyr Ser Lys Leu Thr Val Asp Lys Ser Arg Trp Gln Gln Gly Asn 
    290                 295                 300                 


Val Phe Ser Cys Ser Val Met His Glu Ala Leu His Asn His Tyr Thr 
305                 310                 315                 320 


Gln Lys Ser Leu Ser Leu Ser Pro Gly Lys 
                325                 330 


<210> 468
<211> 552
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 468
Arg Glu Val Leu Val Pro Glu Gly Pro Leu Tyr Arg Val Ala Gly Thr 
1               5                   10                  15      


Ala Val Ser Ile Ser Cys Asn Val Thr Gly Tyr Glu Gly Pro Ala Gln 
            20                  25                  30          


Gln Asn Phe Glu Trp Phe Leu Tyr Arg Pro Glu Ala Pro Asp Thr Ala 
        35                  40                  45              


Leu Gly Ile Val Ser Thr Lys Asp Thr Gln Phe Ser Tyr Ala Val Phe 
    50                  55                  60                  


Lys Ser Arg Val Val Ala Gly Glu Val Gln Val Gln Arg Leu Gln Gly 
65                  70                  75                  80  


Asp Ala Val Val Leu Lys Ile Ala Arg Leu Gln Ala Gln Asp Ala Gly 
                85                  90                  95      


Ile Tyr Glu Cys His Thr Pro Ser Thr Asp Thr Arg Tyr Leu Gly Ser 
            100                 105                 110         


Tyr Ser Gly Lys Val Glu Leu Arg Val Leu Pro Asp Val Leu Gln Val 
        115                 120                 125             


Ser Ala Ala Pro Pro Gly Pro Arg Gly Arg Gln Ala Pro Thr Ser Pro 
    130                 135                 140                 


Pro Arg Met Thr Val His Glu Gly Gln Glu Leu Ala Leu Gly Cys Leu 
145                 150                 155                 160 


Ala Arg Thr Ser Thr Gln Lys His Thr His Leu Ala Val Ser Phe Gly 
                165                 170                 175     


Arg Ser Val Pro Glu Ala Pro Val Gly Arg Ser Thr Leu Gln Glu Val 
            180                 185                 190         


Val Gly Ile Arg Ser Asp Leu Ala Val Glu Ala Gly Ala Pro Tyr Ala 
        195                 200                 205             


Glu Arg Leu Ala Ala Gly Glu Leu Arg Leu Gly Lys Glu Gly Thr Asp 
    210                 215                 220                 


Arg Tyr Arg Met Val Val Gly Gly Ala Gln Ala Gly Asp Ala Gly Thr 
225                 230                 235                 240 


Tyr His Cys Thr Ala Ala Glu Trp Ile Gln Asp Pro Asp Gly Ser Trp 
                245                 250                 255     


Ala Gln Ile Ala Glu Lys Arg Ala Val Leu Ala His Val Asp Val Gln 
            260                 265                 270         


Thr Leu Ser Ser Gln Leu Ala Val Thr Val Gly Pro Gly Glu Arg Arg 
        275                 280                 285             


Ile Gly Pro Gly Glu Pro Leu Glu Leu Leu Cys Asn Val Ser Gly Ala 
    290                 295                 300                 


Leu Pro Pro Ala Gly Arg His Ala Ala Tyr Ser Val Gly Trp Glu Met 
305                 310                 315                 320 


Ala Pro Ala Gly Ala Pro Gly Pro Gly Arg Leu Val Ala Gln Leu Asp 
                325                 330                 335     


Thr Glu Gly Val Gly Ser Leu Gly Pro Gly Tyr Glu Gly Arg His Ile 
            340                 345                 350         


Ala Met Glu Lys Val Ala Ser Arg Thr Tyr Arg Leu Arg Leu Glu Ala 
        355                 360                 365             


Ala Arg Pro Gly Asp Ala Gly Thr Tyr Arg Cys Leu Ala Lys Ala Tyr 
    370                 375                 380                 


Val Arg Gly Ser Gly Thr Arg Leu Arg Glu Ala Ala Ser Ala Arg Ser 
385                 390                 395                 400 


Arg Pro Leu Pro Val His Val Arg Glu Glu Gly Val Val Leu Glu Ala 
                405                 410                 415     


Val Ala Trp Leu Ala Gly Gly Thr Val Tyr Arg Gly Glu Thr Ala Ser 
            420                 425                 430         


Leu Leu Cys Asn Ile Ser Val Arg Gly Gly Pro Pro Gly Leu Arg Leu 
        435                 440                 445             


Ala Ala Ser Trp Trp Val Glu Arg Pro Glu Asp Gly Glu Leu Ser Ser 
    450                 455                 460                 


Val Pro Ala Gln Leu Val Gly Gly Val Gly Gln Asp Gly Val Ala Glu 
465                 470                 475                 480 


Leu Gly Val Arg Pro Gly Gly Gly Pro Val Ser Val Glu Leu Val Gly 
                485                 490                 495     


Pro Arg Ser His Arg Leu Arg Leu His Ser Leu Gly Pro Glu Asp Glu 
            500                 505                 510         


Gly Val Tyr His Cys Ala Pro Ser Ala Trp Val Gln His Ala Asp Tyr 
        515                 520                 525             


Ser Trp Tyr Gln Ala Gly Ser Ala Arg Ser Gly Pro Val Thr Val Tyr 
    530                 535                 540                 


Pro Tyr Met His Ala Leu Asp Thr 
545                 550         


<210> 469
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="T"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "I"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S" or "I"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 469
Gly Phe Ser Leu Arg Asp Tyr Ala 
1               5               


<210> 470
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 470
Ile Ser Gly Ser Gly Gly Asn Thr 
1               5               


<210> 471
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A" or "S"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="L" or "S"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="A" or "Y" or "V" or "G" or "S"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L" or "S"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Y" or "P" or "T" or "I" or "N" or "K" or "H" or "Q"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="V" or "F" or "I" or "G" or "R" or "H"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Y" or "V" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A" or "T" or "P" or "K" or "S" or "Q"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 471
Glu Arg Trp Arg Leu Leu Ala Tyr 
1               5               


<210> 472
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 472
Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210> 473
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 473
Ile Trp Asp Asp Gly Ser Tyr Lys 
1               5               


<210> 474
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "S"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="L" or "M"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="I" or "S"

<220>
<221> SITE
<222> (1)..(11)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 474
Ala Val Gly Tyr Ser Asp Ser Tyr Arg Ala Leu 
1               5                   10      


<210> 475
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 475
Gly Tyr Thr Phe Thr Asn Asp Ile 
1               5               


<210> 476
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 476
Ile Asn Ala Gly Tyr Gly Asn Thr 
1               5               


<210> 477
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="I"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="Y"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 477
Ala Arg Gly Tyr Tyr Arg Ser Pro Thr Trp Phe Asp Trp 
1               5                   10              


<210> 478
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 478
Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210> 479
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 479
Ile Trp Asp Asp Gly Ser Tyr Lys 
1               5               


<210> 480
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="G"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="I"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 480
Ala Arg Asp Gly Ser Val Trp Val Tyr Ala Phe Asp Leu 
1               5                   10              


<210> 481
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 481
Gly Phe Thr Val Asn Ser Phe Ala 
1               5               


<210> 482
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 482
Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210> 483
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any acidic residue (D/E)

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="I"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 483
Ala Arg Xaa Val Xaa Gly Tyr Gly Ala Phe Ala Leu 
1               5                   10          


<210> 484
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "S"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 484
Gly Phe Thr Phe Arg Asp Phe Ala 
1               5               


<210> 485
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 485
Ile Ser Gly Ser Gly Gly Asn Thr 
1               5               


<210> 486
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="G"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="F" or "I"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Y" or "H" or "S"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 486
Ala Arg Val Gly Trp Glu Val Arg Thr Pro Gly Asp Leu Asp Asp 
1               5                   10                  15  


<210> 487
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 487
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210> 488
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 488
Ile Thr Gly Ser Gly Gly Ser Thr 
1               5               


<210> 489
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="G"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace=" "

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "S"

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any acidic residue(D/E)

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Y" or "I" or "V"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 489
Ala Arg Asp Arg Gly Ala Leu Xaa Leu 
1               5                   


<210> 490
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 490
Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210> 491
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 491
Ile Ser Ser Ser Ser Ser Tyr Ile 
1               5               


<210> 492
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Q"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="L"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="L"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "L"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="C" or "G"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="F" or "V"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="A"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="P" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 492
Cys Arg Pro Tyr Tyr Phe Trp Ser Cys Trp Asp Trp Tyr Asp His 
1               5                   10                  15  


<210> 493
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "S"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 493
Gly Phe Thr Phe Arg Asp Phe Ala 
1               5               


<210> 494
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 494
Ile Ser Gly Ser Gly Gly Asn Thr 
1               5               


<210> 495
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A" or "S"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S" or "I"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="G"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="Y" or "S"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "I"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="G" or "C"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="W" or "G" or "C"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="H" or "T"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="S" or "I"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="W" or "C" or "G" or "R"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="F" or "V" or "C"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="D" or "A"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="H" or "S" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 495
Glu Arg Val Ala Asp Tyr Arg Val Leu Pro Arg Leu Leu Tyr Pro 
1               5                   10                  15  


<210> 496
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 496
Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210> 497
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 497
Ile Thr Gly Ser Gly Gly Ser Thr 
1               5               


<210> 498
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="W"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="P" or "R" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="H" or "P" or "S"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="S"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="I" or "N"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="P"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="W"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 498
Ala Phe Asp Arg Asp Leu Asp Ser 
1               5               


<210> 499
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="N" or "D"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 499
Gly Gly Thr Phe Ser Ser Tyr Gly 
1               5               


<210> 500
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 500
Ile Ile Pro Ile Phe Gly Thr Ala 
1               5               


<210> 501
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="S" or "F" or "D"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "Any aromatic residue (F/Y/W)"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 501
Ser Ser Tyr Tyr Ser Tyr Ser Cys Tyr 
1               5                   


<210> 502
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="T"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "L" or "I"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "K"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="S"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 502
Cys Tyr Pro Tyr Asn His Tyr Tyr 
1               5               


<210> 503
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 503
Ile Asn Pro Tyr Thr Gly Ser Ala 
1               5               


<210> 504
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="R" or "K" or "G"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="N" or "A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D" or "T" or "A"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="K" or "T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="R" or "V" or "G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="H" or "R" or "L"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="N" or "P" or "L" or "Q"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="N" or "K" or "I" or "T"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="G" or "V" or "C" or "A"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="R" or "L" or "I"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="N" or "G" or "V" or "Y" or "A" or "Any acidic residue
      (D/E)"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="V" or "F" or "L" or "A"

<220>
<221> SITE
<222> (1)..(14)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 504
Ser Ser His Ser Pro Glu Ser His Tyr His Ser Met His Ile 
1               5                   10                  


<210> 505
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "V"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 505
Gly Phe Thr Cys Asn Ser Phe Ala 
1               5               


<210> 506
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 506
Ile Ser Gly Ser Gly Gly Gly Thr 
1               5               


<210> 507
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="K" or "T" or "Q"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="R" or "L"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="L"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="L" or "G"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="L" or "I"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="S" or "D"

<220>
<221> SITE
<222> (1)..(16)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 507
Glu Asn Asp Ser Ser Pro Tyr Tyr Phe Trp Ser Gly Ala Phe Asp Tyr 
1               5                   10                  15      


<210> 508
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S" or "R"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "D"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "F"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 508
Cys Phe Thr Phe Asn Ser Tyr Ser 
1               5               


<210> 509
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="N" or "T" or "G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 509
Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210> 510
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="L" or "G"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "G"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "G"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="L" or "V"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="P" or "T"

<220>
<221> SITE
<222> (1)..(16)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 510
Glu Cys Arg Pro Tyr Tyr Phe Trp Ser Cys Trp Asp Trp Phe Ala His 
1               5                   10                  15      


<210> 511
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="F" or "L"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S" or "R"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "D"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "F"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 511
Val Tyr Thr Phe Asn Ser Tyr Ser 
1               5               


<210> 512
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="N" or "T" or "G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 512
Ile Ser Gly Ser Ser Gly Ser Thr 
1               5               


<210> 513
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="K" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="T" or "A"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="R" or "G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="R" or "L"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="P"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="N" or "K" or "I" or "Y" or "T"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="V" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="I" or "V"

<220>
<221> SITE
<222> (1)..(14)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 513
Ser Arg Asn Asp Lys Glu His His Tyr Ser Gly Met Tyr Gly 
1               5                   10                  


<210> 514
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="T"

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any acidic residue (D/E)

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 514
Gly Tyr Thr Leu Ser Xaa Leu Ser 
1               5               


<210> 515
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Q"

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="T"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 515
Phe Asp Pro Glu Xaa Asn Glu Ile 
1               5               


<210> 516
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="K" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="V"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="R"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="G"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="L"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="T"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (19)..(19)
<223> /replace="G"

<220>
<221> VARIANT
<222> (20)..(20)
<223> /replace="I"

<220>
<221> SITE
<222> (1)..(22)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 516
Ala Asn Tyr Leu Trp Tyr Tyr Tyr Tyr Ser Ser Val Tyr Tyr Gly Arg 
1               5                   10                  15      


Asn Tyr Val Met Asp Val 
            20          


<210> 517
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="R" or "N"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 517
Gly Tyr Thr Phe Thr Ser Tyr Ser 
1               5               


<210> 518
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="V"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="F" or "V" or "A"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="N"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 518
Ile Ser Thr Tyr Ser Gly Asn Thr 
1               5               


<210> 519
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L" or "V"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="G"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="S" or "D"

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="R"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="R" or "N"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="G"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="D"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="G"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="L"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="T"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="D"

<220>
<221> VARIANT
<222> (19)..(19)
<223> /replace="C" or "G"

<220>
<221> VARIANT
<222> (20)..(20)
<223> /replace="L" or "I"

<220>
<221> VARIANT
<222> (22)..(22)
<223> /replace="I" or "V"

<220>
<221> SITE
<222> (1)..(22)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 519
Glu Lys Tyr Phe Val Tyr Tyr Tyr Xaa Ser Ser Val Tyr Tyr Arg Arg 
1               5                   10                  15      


Asn Tyr Ser Met Asp Phe 
            20          


<210> 520
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="L"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "V"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 520
Arg Phe Thr Cys Asn Asp Tyr Ser 
1               5               


<210> 521
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="H" or "R"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 521
Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210> 522
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="L"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D"

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="G"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="R"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="G"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="L" or "C" or "Any aromatic residue (F/Y/W)"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="G"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="F" or "V"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="P"

<220>
<221> SITE
<222> (1)..(16)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 522
Glu Cys Arg Pro Tyr Xaa Phe Trp Ser Cys Gly His Trp Cys Asp Leu 
1               5                   10                  15      


<210> 523
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 523
Arg Phe Thr Phe Asp Asp Tyr Ser 
1               5               


<210> 524
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 524
Ile Ser Trp Asn Ser Gly Arg Ile 
1               5               


<210> 525
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="F" or "V"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="F" or "L"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="S" or "D"

<220>
<221> SITE
<222> (1)..(11)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 525
Ala Arg Tyr Gly Tyr Pro Cys Tyr Cys Asp Tyr 
1               5                   10      


<210> 526
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="R"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "L"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 526
Val Tyr Tyr Phe Ser Asn Tyr Trp 
1               5               


<210> 527
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 527
Ile Asp Pro Ser Asn Ser Tyr Thr 
1               5               


<210> 528
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="R"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L" or "I" or "A"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="T" or "A"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="T" or "G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "R" or "G"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="H" or "N"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="K" or " " or "Y" or "T"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="G"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="R"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="V" or "G"

<220>
<221> SITE
<222> (1)..(14)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 528
Ala Ser Ala Arg Lys Ala Ser Arg Tyr Asn Cys Met Asp Phe 
1               5                   10                  


<210> 529
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="F"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 529
Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210> 530
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="N" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="G"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="R" or "T" or "G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 530
Ile Ser Ala Ser Ser Thr Ser Thr 
1               5               


<210> 531
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D"

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="R"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="S"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="R" or "G"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="R"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="K" or "T"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (20)..(20)
<223> /replace="I"

<220>
<221> VARIANT
<222> (21)..(21)
<223> /replace="D"

<220>
<221> SITE
<222> (1)..(22)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 531
Ala Lys Asp Leu Gly Tyr Tyr Tyr Xaa Ser Ser Gly Tyr Tyr Glu His 
1               5                   10                  15      


Asn Tyr Gly Met Asn Val 
            20          


<210> 532
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S" or "R"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="F"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 532
Gly Phe Thr Phe Asn Ser Tyr Ser 
1               5               


<210> 533
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="N" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="G"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="N" or "G" or "R" or "T"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 533
Ile Ser Ala Ser Ser Thr Ser Thr 
1               5               


<210> 534
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="R"

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="T" or "A"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="R"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="S"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="P"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="R"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="D"

<220>
<221> VARIANT
<222> (19)..(19)
<223> /replace="D" or "G"

<220>
<221> VARIANT
<222> (20)..(20)
<223> /replace="L"

<220>
<221> VARIANT
<222> (21)..(21)
<223> /replace="D"

<220>
<221> VARIANT
<222> (22)..(22)
<223> /replace="V"

<220>
<221> SITE
<222> (1)..(22)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 534
Ala Ser Arg Gly Xaa Tyr Tyr Ser Ser Glu Ser Tyr Tyr Arg His His 
1               5                   10                  15      


Arg Tyr Cys Met Asn Ile 
            20          


<210> 535
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="T"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 535
Gly Tyr Asn Phe Thr Arg Tyr Gly 
1               5               


<210> 536
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 536
Ile Ser Thr Tyr Ser Gly Asn Thr 
1               5               


<210> 537
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L" or "I" or "A"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="T" or "A"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="A" or "T" or "G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="R" or "V" or "D" or "C"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="H" or "R" or "Q"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="N" or " "

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="I"

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="V"

<220>
<221> SITE
<222> (1)..(14)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 537
Ser Arg Ala Arg Ser Ser Gly Tyr Tyr Tyr Cys Met Xaa Ile 
1               5                   10                  


<210> 538
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="V"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 538
Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210> 539
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 539
Ile Trp Asp Asp Gly Ser Tyr Lys 
1               5               


<210> 540
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="A"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="R"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="T"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="R" or "L" or "I"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "A"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="L"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="L" or "I"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="C" or "L" or "G"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="L" or "V"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="P" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 540
Ala Ser Ser Met Tyr Pro Met Ser Arg Arg Trp Trp Phe Asp His 
1               5                   10                  15  


<210> 541
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S" or "R"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="F"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 541
Gly Phe Thr Phe Asn Ser Tyr Ala 
1               5               


<210> 542
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="N" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="G"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="R" or "N" or "G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 542
Ile Ser Ala Ser Gly Thr Ser Thr 
1               5               


<210> 543
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "T"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="K" or "Q"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="G"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="D"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="P"

<220>
<221> VARIANT
<222> (21)..(21)
<223> /replace="D"

<220>
<221> SITE
<222> (1)..(22)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 543
Ala Arg Asp Ser His Val Ala Ser Thr Gly Arg Gly Val Val Tyr His 
1               5                   10                  15      


Tyr His Gly Met Asn Val 
            20          


<210> 544
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 544
Arg Phe Thr Phe Asn Tyr Tyr Ser 
1               5               


<210> 545
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="R"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 545
Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210> 546
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="L"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="H" or "N" or "Q"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="L" or "V"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="K" or "Y" or "Q" or "T" or "A"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 546
Ala Arg Ser Arg Thr Arg Asp Ser 
1               5               


<210> 547
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 547
Gly Tyr Thr Phe Thr Asn Tyr Tyr 
1               5               


<210> 548
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 548
Ile Asn Pro Tyr Thr Gly Ser Ala 
1               5               


<210> 549
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="F" or "L" or "V"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="G"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="L"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="R" or "L" or "I"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="G"

<220>
<221> SITE
<222> (1)..(16)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 549
Ala Arg Asp Pro Cys Gly Val Val Asn His Phe Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210> 550
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 550
Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210> 551
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 551
Ile Asn His Ser Gly Ser Thr 
1               5           


<210> 552
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="A"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="R"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="R"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="A"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "L"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="G"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="R" or "L"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="V"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 552
Glu Met Pro Tyr His Ser Ser Trp Glu Ser Tyr Tyr Tyr Val Met Asp 
1               5                   10                  15      


Phe 
    


<210> 553
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 553
Gly Tyr Thr Phe Thr Asn Tyr Tyr 
1               5               


<210> 554
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 554
Ile Asn Pro Tyr Thr Gly Ser Ala 
1               5               


<210> 555
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="F" or "V" or "A"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L" or "I"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="A"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="T" or "A"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="I" or "G"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="L"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="D" or "V" or "G"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="R" or "I"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="D"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="V"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 555
Ala Arg Ser Arg Gly Ser Cys Arg Tyr Cys Met Asn Ile 
1               5                   10              


<210> 556
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="V"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 556
Gly Phe Thr Phe Asn Ser Phe Ala 
1               5               


<210> 557
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 557
Ile Ser Gly Ser Gly Gly Gly Thr 
1               5               


<210> 558
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="L"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="W" or "G"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="L"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="H" or "N" or "Q"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="R" or "I" or "V" or "L"

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any acidic residue (D/E)

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="K" or "T"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 558
Ala Arg Ser Arg Thr Gly Xaa Ser 
1               5               


<210> 559
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="G"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 559
Gly Tyr Thr Phe Thr Arg Tyr Cys 
1               5               


<210> 560
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 560
Ile Ser Thr Tyr Ser Gly Asn Thr 
1               5               


<210> 561
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="K"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="L"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "D"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="V" or "G"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="D"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="D" or "G"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="I"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="I" or "V"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 561
Ala Arg Gly Trp Arg Pro Tyr Arg Trp His Tyr Cys Met Asn Phe 
1               5                   10                  15  


<210> 562
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "P" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="V" or "I" or "R"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "L" or "I" or "M"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "T"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 562
Lys Ser Asn His Lys Tyr 
1               5       


<210> 563
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 563
Ala Ala Ser 
1           


<210> 564
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "S" or "T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "S" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="N" or "S" or "T"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 564
Leu Leu Ser Tyr Pro Pro Pro Leu Pro 
1               5                   


<210> 565
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 565
Gln Gly Ile Ser Thr Phe 
1               5       


<210> 566
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 566
Ala Ala Ser 
1           


<210> 567
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 567
Gln Gln Thr Tyr Ser Thr Gln Trp Thr 
1               5                   


<210> 568
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 568
Gln Ser Ile Ser Ser Trp 
1               5       


<210> 569
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 569
Lys Ala Ser 
1           


<210> 570
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 570
Gln Gln Tyr Gly Asp Tyr Pro Tyr Thr 
1               5                   


<210> 571
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "P" or "H"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="N" or "I" or "L"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="I" or "R"

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any acidic residue (D/E)

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 571
Lys Asp Ser Ser Xaa Tyr 
1               5       


<210> 572
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 572
Asp Ala Ala 
1           


<210> 573
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="K" or "H" or "L"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "D" or "F"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="F" or "V"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="P" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="S" or "F" or "D"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="N" or "S" or "T"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 573
Leu Gln Tyr Val Ser Leu His Tyr Pro 
1               5                   


<210> 574
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="P" or "Any basic residue (R/H/K)"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="N" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "L" or "I" or "M"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="R" or "I" or "S"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "D" or "S" or "K" or "T" or "I"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 574
Gln Ser Asn His His Tyr 
1               5       


<210> 575
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 575
Gly Ala Ser 
1           


<210> 576
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "K" or "L" or "P"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="E" or "Q" or "K" or "L" or "P"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="A" or "S" or "T" or "P"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="S" or "V" or "L" or "F"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="Q" or "K" or "R" or "T" or "P"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="F"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="N" or "S" or "T"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 576
His His Asn Tyr Ser Val Ala Tyr Pro 
1               5                   


<210> 577
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 577
His Arg Ile Phe Ser Tyr 
1               5       


<210> 578
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 578
Gly Ala Ser 
1           


<210> 579
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 579
Gln Gln Ser Phe Ser Asp Pro Tyr Thr 
1               5                   


<210> 580
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "P" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="V" or "I" or "R"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "L" or "I" or "M"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "T"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 580
Lys Ser Asn His Lys Tyr 
1               5       


<210> 581
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 581
Ser Ala Ser 
1           


<210> 582
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "S" or "T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "S" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="N" or "S" or "T"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 582
Leu Leu Ser Tyr Pro Pro Pro Leu Pro 
1               5                   


<210> 583
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="L" or "P" or "Any basic residue (R/H/K)"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S" or "G" or "R" or "T" or "I"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "L" or "V" or "T" or "I"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="N" or "S" or "G" or "R" or "T" or "I"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="A" or "S" or "E" or "T" or "P" or "I"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "S" or "Y"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 583
Gln Asp Asn His Asn Gln 
1               5       


<210> 584
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 584
Asp Ala Ser 
1           


<210> 585
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "Q" or "L" or "P" or "Any basic residue (R/H/K)"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="E" or "Q" or "L" or "P" or "Any basic residue (R/H/K)"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="G" or "R" or "T" or "I"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="H" or "D" or "S" or "F"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="G" or "R" or "T" or "I" or "M"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="A" or "S" or "T" or "P" or "I"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="L" or "V" or "R" or "I"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="S" or "Q" or "T" or "P" or "Any basic residue (R/H/K)"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="H" or "N" or "S" or "F" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="A" or "S" or "T" or "P"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 585
Asn Asn Ser Tyr Ser Asn His Ala Tyr Asn 
1               5                   10  


<210> 586
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="R" or "L"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S" or "N" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="F" or "L"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="S" or "K" or "T" or "P"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="L" or "V" or "F" or "I"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 586
Gln Ala Val Gly Ala Tyr 
1               5       


<210> 587
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 587
Gly Val Ser 
1           


<210> 588
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "L" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="K" or "H" or "L"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="I" or "T" or "R"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="H" or "D" or "Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="A" or "Any acidic residue (D/E)"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "V" or "L" or "F"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="R" or "L"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="S" or "P" or "T"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 588
Lys Gln Ser Asn Val Ala Pro Gly Lys 
1               5                   


<210> 589
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "P" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="V" or "I" or "R"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="S" or "L" or "I" or "M"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "T"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 589
Lys Ser Asn His Lys Tyr 
1               5       


<210> 590
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 590
Ala Ala Ser 
1           


<210> 591
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="Q" or "K" or "H"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="N" or "S" or "T"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "S" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="I" or "R"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="N" or "S" or "T"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 591
Leu Leu Ser Tyr Pro Pro Pro Leu Pro 
1               5                   


<210> 592

<400> 592
000


<210> 593

<400> 593
000


<210> 594

<400> 594
000


<210> 595

<400> 595
000


<210> 596

<400> 596
000


<210> 597

<400> 597
000


<210> 598

<400> 598
000


<210> 599

<400> 599
000


<210> 600

<400> 600
000


<210> 601
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 601
Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210> 602
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 602
Ile Trp Asp Asp Gly Ser Tyr Lys 
1               5               


<210> 603
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 603
Ile Trp Asp Gly Gly Lys Tyr Lys 
1               5               


<210> 604
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 604
Ile Trp Asp Gly Gly Ser Tyr Lys 
1               5               


<210> 605
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 605
Ala Arg Asp Gly Ser Gly Trp Gly Tyr Ala Phe Asp Ile 
1               5                   10              


<210> 606
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 606
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser 
            20                  25  


<210> 607
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 607
Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala 
1               5                   10                  15      


Val 
    


<210> 608
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 608
Tyr Tyr Gly Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn 
1               5                   10                  15      


Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp 
            20                  25                  30          


Thr Ala Val Tyr Tyr Cys 
        35              


<210> 609
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 609
Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
1               5                   10      


<210> 610
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 610
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 611
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 611
Gln Asp Ile Ser Glu Tyr 
1               5       


<210> 612
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 612
Gln Asp Ile Ser Lys Pro 
1               5       


<210> 613
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 613
Gln Asp Ile Thr Lys Gly 
1               5       


<210> 614
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 614
Gln Asp Ile Gly Pro Trp 
1               5       


<210> 615
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 615
Gln Asp Ile Glu Trp Trp 
1               5       


<210> 616
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 616
Gln Asp Ile Gly Ala Tyr 
1               5       


<210> 617
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 617
Gln Asp Ile Glu Trp Ala 
1               5       


<210> 618
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 618
Gln Asp Ile Met Lys Thr 
1               5       


<210> 619
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 619
Gln Asp Ile Ser Pro Tyr 
1               5       


<210> 620
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 620
Gln Asp Ile Ser Pro Trp 
1               5       


<210> 621
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 621
Gln Asp Ile Gly Pro Tyr 
1               5       


<210> 622
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 622
Gln Asp Ile Ser Tyr Asn 
1               5       


<210> 623
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 623
Asp Ala Ala 
1           


<210> 624
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 624
Arg Ser Pro 
1           


<210> 625
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 625
Gly Ser Pro 
1           


<210> 626
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 626
Ala Arg Asp 
1           


<210> 627
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 627
Thr Ser Ala 
1           


<210> 628
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 628
Gly Ala Asp 
1           


<210> 629
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 629
Asp Ala Pro 
1           


<210> 630
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 630
Ser Gln Pro 
1           


<210> 631
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 631
Gln Gln Tyr Asp Ser Phe Pro Tyr Thr 
1               5                   


<210> 632
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 632
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser 
            20                  25      


<210> 633
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 633
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser 
            20                  25      


<210> 634
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 634
Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
1               5                   10                  15      


Phe 
    


<210> 635
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 635
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
1               5                   10                  15      


Tyr 
    


<210> 636
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 636
Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Ile 
1               5                   10                  15      


Tyr 
    


<210> 637
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 637
Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
1               5                   10                  15      


Phe 
    


<210> 638
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 638
Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala Thr Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro Glu Asp Phe Ala 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 639
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 639
Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 640
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 640
Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Phe Ala 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 641
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 641
Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
1               5                   10  


<210> 642
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 642
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
1               5                   10  


<210> 643
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 643
Gly Phe Thr Phe Arg Asp Tyr Ala 
1               5               


<210> 644
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 644
Ile Ser Gly Ser Gly Gly Asn Thr 
1               5               


<210> 645
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 645
Ile Ser Gly Ser Gly Gly Ser Thr 
1               5               


<210> 646
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 646
Ala Arg Gly Glu Tyr Ser Ser Gly Trp Pro Ser Trp Phe Asp Pro 
1               5                   10                  15  


<210> 647
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 647
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser 
            20                  25  


<210> 648
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 648
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser 
            20                  25  


<210> 649
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 649
Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  15      


Ser 
    


<210> 650
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 650
Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  15      


Ala 
    


<210> 651
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 651
Tyr Tyr Ala Asp Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn 
1               5                   10                  15      


Ser Lys Asn Thr Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp 
            20                  25                  30          


Thr Ala Ile Tyr Tyr Cys 
        35              


<210> 652
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 652
Arg Thr Val Gly Thr Phe 
1               5       


<210> 653
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 653
Gly Val Ser 
1           


<210> 654
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 654
His Thr Ser 
1           


<210> 655
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 655
Gln Gln Ser His Asp Val Pro Arg Thr 
1               5                   


<210> 656
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 656
Glu Ile Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser 
            20                  25      


<210> 657
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 657
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser 
            20                  25      


<210> 658
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 658
Leu Asn Trp Tyr Gln Gln Arg Pro Gly Lys Pro Pro Gln Ala Leu Ile 
1               5                   10                  15      


Leu 
    


<210> 659
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 659
Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
1               5                   10                  15      


Leu 
    


<210> 660
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 660
Ile Leu Glu Gly Gly Val Ser Ser Arg Phe Ser Gly Ala Gly Ser Gly 
1               5                   10                  15      


Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Gly 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 661
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 661
Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Leu Glu Asp Phe Ala 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 662
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 662
Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Gly 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 663
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 663
Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
1               5                   10                  15      


Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala 
            20                  25                  30          


Thr Tyr Tyr Cys 
        35      


<210> 664
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 664
Phe Gly Gln Gly Thr Lys Val Asp Leu Arg 
1               5                   10  


<210> 665
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 665
Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
1               5                   10  


<210> 666

<400> 666
000


<210> 667

<400> 667
000


<210> 668

<400> 668
000


<210> 669
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 669
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Asp Asp Gly Ser Tyr Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Ser Gly Trp Gly Tyr Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210> 670
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 670
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Asp Asp Gly Ser Tyr Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Ser Gly Trp Gly Tyr Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 671
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 671
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Asp Gly Gly Lys Tyr Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Ser Gly Trp Gly Tyr Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 672
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 672
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Asp Gly Gly Ser Tyr Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Ser Gly Trp Gly Tyr Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 673
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 673
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 674
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 674
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Lys Pro 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 675
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 675
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Arg Ser Pro Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 676
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 676
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 677
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 677
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Lys Gly 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 678
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 678
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 679
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 679
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Glu Trp Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 680
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 680
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Ala Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 681
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 681
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Ala Arg Asp Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 682
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 682
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Thr Ser Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 683
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 683
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Glu Trp Ala 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 684
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 684
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Gly Ala Asp Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 685
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 685
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Pro Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 686
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 686
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Ser Gln Pro Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 687
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 687
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Met Lys Thr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys 
            100                 105         


<210> 688
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 688
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 689
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 689
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 690
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 690
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Pro Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 691
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 691
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Glu Trp Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 692
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 692
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Ile 
        35                  40                  45              


Tyr Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 693
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 693
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Ile 
        35                  40                  45              


Tyr Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 694
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 694
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 695
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 695
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 696
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 696
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 697
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 697
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Pro Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 698
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 698
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Tyr Asn 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 699
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 699
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Glu Trp Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Ile 
        35                  40                  45              


Tyr Gly Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 700
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 700
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 701
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 701
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Gly Ala Asp Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 702
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 702
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Gly Pro Trp 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Lys Pro Leu Val 
        35                  40                  45              


Phe Arg Ser Pro Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 703
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 703
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Arg Asp Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Gly Ser Gly Gly Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Glu Tyr Ser Ser Gly Trp Pro Ser Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 704
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 704
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Arg Asp Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Glu Tyr Ser Ser Gly Trp Pro Ser Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 705
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 705
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Asp Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Glu Tyr Ser Ser Gly Trp Pro Ser Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 706
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 706
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Asp Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Glu Tyr Ser Ser Gly Trp Pro Ser Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 707
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 707
Glu Ile Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Arg Pro Gly Lys Pro Pro Gln Ala Leu Ile 
        35                  40                  45              


Leu Gly Val Ser Ile Leu Glu Gly Gly Val Ser Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ala Gly Ser Gly Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Gly Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Asp Leu Arg 
            100                 105         


<210> 708
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 708
Glu Ile Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Arg Pro Gly Lys Pro Pro Gln Ala Leu Ile 
        35                  40                  45              


Leu His Thr Ser Ile Leu Glu Gly Gly Val Ser Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ala Gly Ser Gly Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Gly Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Asp Leu Arg 
            100                 105         


<210> 709
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 709
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Leu Gly Val Ser Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Leu 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 710
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 710
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Leu Gly Val Ser Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Gly Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 711
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 711
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Leu Gly Val Ser Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 712
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 712
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Leu His Thr Ser Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Gly Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 713
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 713
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Ala Leu Ile 
        35                  40                  45              


Leu His Thr Ser Ile Leu Glu Gly Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210> 714
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "L" or "N" or
      "P" or "Q" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 714
Ala Ala Ala Ala Ala Cys Ala Glu 
1               5               


<210> 715
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="D" or "E" or "F" or "H" or "I" or "K" or "M" or "N" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D" or "E" or "F" or "G"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="F" or "H" or "K" or "P" or "R" or "S" or "T" or "W" or
      "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "P" or "Q" or "S" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 715
Ala Ala Cys Ala Asp Cys Ala Ala 
1               5               


<210> 716
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "H" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "F" or "I" or "Q"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "H" or "I" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="E" or "G" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "Q" or "R"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="F" or "G" or "H" or "M" or "N" or "P" or "R" or "T" or
      "W"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="D" or "F" or "K" or "L" or "M" or "P" or "Q" or "R" or
      "W"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="H" or "I" or "K" or "M" or "P" or "Q" or "R" or "W" or
      "Y"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 716
Ala Ala Cys Glu Ala Ala Ala Ala Ala Ala Asp Cys Gly 
1               5                   10              


<210> 717
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D" or "E" or "F" or "G" or "K" or "L" or "M" or "R" or
      "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "L" or "M" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "F" or "G" or "H" or "I" or "Q" or "S" or "T" or
      "W" or "Y"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 717
Ala Ala Ala Cys Cys Ala 
1               5       


<210> 718
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "F" or "G" or "H" or "N" or "R" or "S"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "I" or "K" or "S" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "N" or "P" or
      "S" or "T" or "V" or "W"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 718
Ala Ala Ala 
1           


<210> 719
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "G" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "F" or "P" or "Q" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="K" or "L" or "M" or "N" or "P" or "Q" or "R" or "S"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "E" or "F" or "H" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="E" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 719
Ala Ala Ala Asp Gly Cys Ala Ala Cys 
1               5                   


<210> 720
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="K" or "L" or "M" or "P" or "Q" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "H" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 720
Ala Ala Ala Ala Ile Phe Ala Ala 
1               5               


<210> 721
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "S" or "V" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "F" or "H" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "F" or "G" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 721
Ala Ala Cys Ala Ala Ala Ala Cys 
1               5               


<210> 722
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G" or "H" or "I" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "F" or "H" or "N" or "Q" or "R" or "S" or "T" or
      "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="H" or "I" or "L" or "M" or "N" or "Q" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "F" or "G" or "H" or "K" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "E" or "F" or "H" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "N" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="H" or "I" or "K" or "N" or "P" or "Q" or "R" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="F" or "G" or "H" or "P" or "Q" or "T"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="E" or "F" or "G" or "I" or "K" or "L" or "N" or "P" or
      "Q" or "R" or "S" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 722
Ala Phe Ala Asp Ala Ala Ala Ala Ala Ala Ala Phe Ala Asp Asp 
1               5                   10                  15  


<210> 723
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "M" or
      "N" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="D" or "E" or "H" or "K" or "L" or "M" or "Q" or "T" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "G" or "I" or "L" or "M" or "P" or "Q" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="M" or "P" or "Q" or "T" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "Y"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 723
Ala Cys Ala Cys Cys Ala 
1               5       


<210> 724
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="H" or "I" or "L" or "M" or "N" or "P" or "Q" or "W" or
      "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "G" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 724
Cys Cys Cys 
1           


<210> 725
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="D" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "F" or "G" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="E" or "G" or "K" or "M" or "P" or "S" or "V" or "W"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="H" or "L" or "M" or "P" or "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "L" or "M" or "P" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "E" or "G" or "H" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "M" or
      "N" or "P" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "G" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "S" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 725
Cys Ala Cys Cys Cys Ala Ala Ala Cys 
1               5                   


<210> 726

<400> 726
000


<210> 727

<400> 727
000


<210> 728

<400> 728
000


<210> 729

<400> 729
000


<210> 730

<400> 730
000


<210> 731

<400> 731
000


<210> 732

<400> 732
000


<210> 733

<400> 733
000


<210> 734
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "L" or "N" or
      "P" or "Q" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "S" or "T" or "V" or "W"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 734
Ala Ala Ala Ala Ala Cys Ala Glu Ala Ala 
1               5                   10  


<210> 735
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="D" or "F" or "H" or "I" or "K" or "N" or "P" or "Q" or
      "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "F" or "H" or "I" or "K" or "M" or "N" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "G"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="F" or "H" or "K" or "P" or "R" or "S" or "T" or "W" or
      "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "P" or "Q" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="G" or "I" or "L" or "M" or "P" or "R" or "V" or "W" or
      "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="E" or "G" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="D" or "F" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "S" or "T" or "W"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="D" or "E" or "F" or "H" or "K" or "L" or "M" or "P" or
      "Q" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="F" or "K" or "M" or "N" or "P" or "Q" or "R" or "S" or
      "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="C" or "D" or "F" or "G" or "H" or "K" or "L" or "M" or
      "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 735
Cys Ala Ala Cys Ala Asp Cys Ala Ala Ala Ala Glu Cys Ala Cys Ala 
1               5                   10                  15      


Glu 
    


<210> 736
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "H" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "F" or "I" or "Q"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "H" or "I" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="E" or "G" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "Q" or "R"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="F" or "G" or "H" or "M" or "N" or "P" or "R" or "T" or
      "W"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="D" or "F" or "K" or "L" or "M" or "P" or "Q" or "R" or
      "W"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="H" or "I" or "K" or "M" or "P" or "Q" or "R" or "W" or
      "Y"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 736
Ala Ala Cys Glu Ala Ala Ala Ala Ala Ala Asp Cys Gly 
1               5                   10              


<210> 737
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "F" or "H" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "K" or "L" or "M" or "R" or
      "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "L" or "M" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "F" or "G" or "H" or "I" or "Q" or "S" or "T" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(11)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 737
Ala Ala Ala Ala Ala Ala Cys Cys Ala Ala Ala 
1               5                   10      


<210> 738
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "N" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "E" or "H" or "K" or "L" or "M" or "N" or "P" or
      "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "N" or "P" or
      "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "F" or "G" or "H" or "N" or "R" or "S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "I" or "K" or "S" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "N" or "P" or
      "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "E" or "G" or "H" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "N" or "P" or "Q" or "R" or "T" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="E" or "F" or "H" or "I" or "M" or "N" or "P" or "R" or
      "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="D" or "E" or "F" or "G" or "H" or "L" or "M" or "N" or
      "Q" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 738
Ala Ala Ala Ala Ala Ala Ala Ala Ala Ala Cys Cys 
1               5                   10          


<210> 739
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "G" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "F" or "P" or "Q" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="K" or "L" or "M" or "N" or "P" or "Q" or "R" or "S"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "E" or "F" or "H" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="E" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 739
Ala Ala Ala Asp Gly Cys Ala Ala Cys 
1               5                   


<210> 740
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="K" or "L" or "M" or "P" or "Q" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "H" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 740
Ala Ala Ala Ala Ile Phe Ala Ala Ala Ala 
1               5                   10  


<210> 741
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "H" or "K" or "L" or "N" or
      "P" or "Q" or "R" or "S" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "S" or "V" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "F" or "H" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "F" or "G" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "E" or "H" or "K" or "L" or "M" or "P" or "S" or
      "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 741
Ala Ala Ala Cys Ala Ala Ala Ala Cys Ala Ala Ala Ala Ala Ala Ala 
1               5                   10                  15      


Ala 
    


<210> 742
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G" or "H" or "I" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "F" or "H" or "N" or "Q" or "R" or "S" or "T" or
      "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="H" or "I" or "L" or "M" or "N" or "Q" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "F" or "G" or "H" or "K" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "E" or "F" or "H" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "N" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="H" or "I" or "K" or "N" or "P" or "Q" or "R" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="F" or "G" or "H" or "P" or "Q" or "T"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="E" or "F" or "G" or "I" or "K" or "L" or "N" or "P" or
      "Q" or "R" or "S" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 742
Ala Phe Ala Asp Ala Ala Ala Ala Ala Ala Ala Phe Ala Asp Asp 
1               5                   10                  15  


<210> 743
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "L" or
      "M" or "N" or "P" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "M" or
      "N" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "H" or "K" or "L" or "M" or "Q" or "T" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="E" or "G" or "I" or "L" or "M" or "P" or "Q" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="M" or "P" or "Q" or "T" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="D" or "E" or "F" or "G" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(11)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 743
Ala Ala Ala Ala Cys Ala Cys Cys Ala Ala Cys 
1               5                   10      


<210> 744
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "N" or "P" or "R" or "S" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "G" or "H" or "K" or "M" or "N" or
      "Q" or "T" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="H" or "I" or "L" or "M" or "N" or "P" or "Q" or "W" or
      "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "G" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="E" or "G" or "I" or "L" or "M" or "P" or "R" or "S" or
      "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 744
Ala Ala Ala Ala Leu Cys Cys Cys Ile Ala Cys Ala 
1               5                   10          


<210> 745
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="D" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "F" or "G" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="E" or "G" or "K" or "M" or "P" or "S" or "V" or "W"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="H" or "L" or "M" or "P" or "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "L" or "M" or "P" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "E" or "G" or "H" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "M" or
      "N" or "P" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "G" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "S" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 745
Cys Ala Cys Cys Cys Ala Ala Ala Cys 
1               5                   


<210> 746

<400> 746
000


<210> 747

<400> 747
000


<210> 748

<400> 748
000


<210> 749

<400> 749
000


<210> 750

<400> 750
000


<210> 751

<400> 751
000


<210> 752

<400> 752
000


<210> 753

<400> 753
000


<210> 754
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "L" or "N" or
      "P" or "Q" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 754
Ala Ala Ala Ala Ala Cys Ala Glu 
1               5               


<210> 755
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "A"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="R"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "P" or "Q" or "S" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 755
Ala Arg Cys Gly Asp Lys Ala Ala 
1               5               


<210> 756
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "H" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "F" or "I" or "Q"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="E" or "G" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "Q" or "R"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="F" or "G" or "H" or "M" or "N" or "P" or "R" or "T" or
      "W"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="K"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="H" or "I" or "K" or "M" or "P" or "Q" or "R" or "W" or
      "Y"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 756
Ala Ala Cys Glu Ala Ala Tyr Ala Ala Ala Asp Arg Gly 
1               5                   10              


<210> 757
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="G" or "K" or "M" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="F" or "G" or "L" or "M" or "P" or "Q" or "S" or "T" or
      "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "G" or "Q" or "S" or "T" or "W"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 757
Ala Ala Ala Glu Asp Ala 
1               5       


<210> 758
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="G" or "H" or "N" or "R" or "S"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="S" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "F" or "H" or "N" or "P" or "T" or "V" or
      "W"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 758
Ala Asp Ala 
1           


<210> 759
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "G" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Q" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="R" or "K"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "L" or "M" or "N" or "Q" or "S" or "T" or "V"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="E" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 759
Ala Ala Ala Glu Gly Asp Ala Ala Cys 
1               5                   


<210> 760
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "H" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="N" or "S"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 760
Arg Gly Ala Ala Lys Phe Phe Ala 
1               5               


<210> 761
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "S" or "V" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="K" or "N" or "R" or "S" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(8)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 761
Ala Ala Cys Met Phe Ala Gly Cys 
1               5               


<210> 762
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G" or "H" or "I" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="H" or "I" or "L" or "M" or "N" or "Q" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "F" or "G" or "H" or "K" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "E" or "F" or "H" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "N" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="E" or "F" or "G" or "I" or "K" or "L" or "N" or "P" or
      "Q" or "R" or "S" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 762
Ala Phe Ala Asp Ala Ala Ala Ala Ala Ala Ala Phe Ala Thr Asp 
1               5                   10                  15  


<210> 763
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="E" or "G" or "I" or "L" or "M" or "P" or "Q" or "V" or
      "W" or "Y"

<220>
<221> SITE
<222> (1)..(6)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 763
Glu Asp Ala Cys Pro Tyr 
1               5       


<210> 764
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="Q"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="T" or "V"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "G" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(3)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 764
His Ser Cys 
1           


<210> 765
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="D" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "F" or "G" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="H" or "L" or "M" or "P" or "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "P" or "R" or "W"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "M" or
      "N" or "P" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="P" or "S" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 765
Cys Ala Pro Cys Phe Ala Ala Asp Cys 
1               5                   


<210> 766

<400> 766
000


<210> 767

<400> 767
000


<210> 768

<400> 768
000


<210> 769

<400> 769
000


<210> 770

<400> 770
000


<210> 771

<400> 771
000


<210> 772

<400> 772
000


<210> 773

<400> 773
000


<210> 774
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "L" or "N" or
      "P" or "Q" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "S" or "T" or "V" or "W"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 774
Ala Ala Ala Ala Ala Cys Ala Glu Ala Ala 
1               5                   10  


<210> 775
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="D" or "F" or "H" or "I" or "K" or "N" or "P" or "Q" or
      "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "A"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="R"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "P" or "Q" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="G" or "I" or "L" or "M" or "P" or "R" or "V" or "W" or
      "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="E" or "G" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (14)..(14)
<223> /replace="D" or "F" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "S" or "T" or "W"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="D" or "E" or "F" or "H" or "K" or "L" or "M" or "P" or
      "Q" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="C" or "D" or "F" or "G" or "H" or "K" or "L" or "M" or
      "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (18)..(18)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(18)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 775
Ala Cys Ala Arg Cys Gly Asp Lys Ala Ala Ala Ala Val Cys Ala Phe 
1               5                   10                  15      


Ala Glu 
        


<210> 776
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "H" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "F" or "I" or "Q"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="F" or "G" or "H" or "I" or "K" or "L" or "M" or "N" or
      "P" or "Q"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "F" or "G" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="E" or "G" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "Q" or "R"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="F" or "G" or "H" or "M" or "N" or "P" or "R" or "T" or
      "W"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="K"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="H" or "I" or "K" or "M" or "P" or "Q" or "R" or "W" or
      "Y"

<220>
<221> SITE
<222> (1)..(13)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 776
Ala Ala Cys Glu Ala Ala Tyr Ala Ala Ala Asp Arg Gly 
1               5                   10              


<210> 777
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="D" or "E" or "F" or "H" or "K" or "L" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="G" or "K" or "M" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="F" or "G" or "L" or "M" or "P" or "Q" or "S" or "T" or
      "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "G" or "Q" or "S" or "T" or "W"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(11)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 777
Ala Ala Ala Ala Ala Ala Glu Asp Ala Ala Ala 
1               5                   10      


<210> 778
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="R"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "N" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "E" or "H" or "K" or "L" or "M" or "N" or "P" or
      "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "N" or "P" or
      "Q" or "R" or "T" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "H" or "N" or "R" or "S"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="S" or "T"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "F" or "H" or "N" or "P" or "T" or "V" or
      "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="E" or "F" or "H" or "I" or "M" or "N" or "P" or "R" or
      "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="D" or "E" or "F" or "G" or "H" or "L" or "M" or "N" or
      "Q" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 778
Lys Ala Ala Ala Ala Ala Asp Ala Ile Phe Cys Cys 
1               5                   10          


<210> 779
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "M" or "N" or
      "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "G" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="Q" or "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="R" or "K"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="E" or "L" or "M" or "N" or "Q" or "S" or "T" or "V"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="E" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 779
Ala Ala Ala Glu Gly Asp Ala Ala Cys 
1               5                   


<210> 780
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="G" or "H" or "I" or "K" or "L" or "M" or "P" or "Q" or
      "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="N" or "S"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(10)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 780
Arg Gly Ala Ala Lys Phe Phe Ala Ala Ala 
1               5                   10  


<210> 781
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "P" or "Q" or "R" or "S" or "V" or "Y"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="D" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "Q" or "R" or "S" or "V"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="K" or "N" or "R" or "S" or "T"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (16)..(16)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (17)..(17)
<223> /replace="C" or "E" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> SITE
<222> (1)..(17)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 781
Ala Ala Ala Cys Met Phe Ala Gly Cys Lys Ala Ala Ala Asn Ala Ala 
1               5                   10                  15      


Ala 
    


<210> 782
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="G" or "H" or "I" or "T"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "F" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (5)..(5)
<223> /replace="H" or "I" or "L" or "M" or "N" or "Q" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "F" or "G" or "H" or "K" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "E" or "F" or "H" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "P" or "Q" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "N" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (11)..(11)
<223> /replace="C" or "E" or "F" or "H" or "I" or "K" or "L" or "M" or
      "N" or "P" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="Y"

<220>
<221> VARIANT
<222> (13)..(13)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "N" or "P" or "Q" or "R" or "S" or "T" or "V" or "W" or 
      "Y"

<220>
<221> VARIANT
<222> (15)..(15)
<223> /replace="E" or "F" or "G" or "I" or "K" or "L" or "N" or "P" or
      "Q" or "R" or "S" or "T"

<220>
<221> SITE
<222> (1)..(15)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 782
Ala Phe Ala Asp Ala Ala Ala Ala Ala Ala Ala Phe Ala Thr Asp 
1               5                   10                  15  


<210> 783
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "L" or
      "M" or "N" or "P" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "Q" or "R" or "S" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "I" or "K" or
      "L" or "M" or "N" or "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "M" or
      "N" or "P" or "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="E" or "G" or "I" or "L" or "M" or "P" or "Q" or "V" or
      "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(11)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 783
Ala Ala Ala Glu Asp Ala Cys Pro Tyr Ala Gly 
1               5                   10      


<210> 784
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="N" or "R"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "E" or "G" or "H" or "K" or "M" or "N" or
      "Q" or "T" or "W"

<220>
<221> VARIANT
<222> (3)..(3)
<223> /replace="C" or "D" or "E" or "F" or "G" or "H" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "R" or "S" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="Q"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="T" or "V"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="D" or "E" or "G" or "H" or "I" or "K" or "L" or "M" or
      "P" or "Q" or "R" or "S" or "W" or "Y"

<220>
<221> VARIANT
<222> (10)..(10)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "L" or
      "M" or "N" or "P" or "Q" or "T" or "W" or "Y"

<220>
<221> VARIANT
<222> (12)..(12)
<223> /replace="I" or "L" or "P"

<220>
<221> SITE
<222> (1)..(12)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<220> 
<221> source
<223> /note="See specification as filed for detailed description of
      substitutions and preferred embodiments"

<400> 784
Lys Ala Ala Val Leu His Ser Cys Ile Ala Arg Ala 
1               5                   10          


<210> 785
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> VARIANT
<222> (1)..(1)
<223> /replace="D" or "F" or "G" or "I" or "K" or "M" or "N" or "P" or
      "Q" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (2)..(2)
<223> /replace="C" or "D" or "F" or "G" or "I" or "L" or "M" or "N" or
      "P" or "Q" or "R" or "S" or "T" or "V" or "W"

<220>
<221> VARIANT
<222> (4)..(4)
<223> /replace="H" or "L" or "M" or "P" or "Q" or "R" or "V" or "W"

<220>
<221> VARIANT
<222> (6)..(6)
<223> /replace="N" or "P" or "R" or "W"

<220>
<221> VARIANT
<222> (7)..(7)
<223> /replace="C" or "D" or "E" or "G" or "H" or "I" or "K" or "M" or
      "N" or "P" or "R" or "S" or "T" or "V" or "W" or "Y"

<220>
<221> VARIANT
<222> (8)..(8)
<223> /replace="P" or "S" or "W"

<220>
<221> VARIANT
<222> (9)..(9)
<223> /replace="D" or "E" or "F" or "G" or "H" or "K" or "L" or "M" or
      "Q" or "R" or "T" or "V" or "W" or "Y"

<220>
<221> SITE
<222> (1)..(9)
<223> /note="Variant residues given in the sequence have no 
      preference with respect to those in the annotations 
      for variant positions"

<400> 785
Cys Ala Pro Cys Phe Ala Ala Asp Cys 
1               5                   


<210> 786
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 786
Asn Tyr Pro Met Thr 
1               5   


<210> 787
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 787
Thr Ile Arg Gly Ser Gly Gly Asp Thr Trp Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210> 788
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 788
Trp Val Gly Arg Asp Ala 
1               5       


<210> 789
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 789
Arg Ser Ser Gln Ser Leu Val Tyr Ser Asp Gly Asn Thr Tyr Leu Asn 
1               5                   10                  15      


<210> 790
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 790
Lys Val Ser Asn Arg Asp Ser 
1               5           


<210> 791
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 791
Met Gln Gly Thr His Trp Pro Tyr Thr 
1               5                   


<210> 792
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 792
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser 
            20                  25                  30  


<210> 793
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 793
Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ser 
1               5                   10                  


<210> 794
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 794
Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu Gln 
1               5                   10                  15      


Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala Lys 
            20                  25                  30          


<210> 795
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 795
Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10      


<210> 796
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 796
Asp Ile Gln Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys 
            20              


<210> 797
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 797
Trp Phe Gln Gln Arg Pro Gly Gln Ser Pro Arg Arg Leu Ile Tyr 
1               5                   10                  15  


<210> 798
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 798
Gly Val Pro Asp Arg Phe Ser Gly Ser Val Ser Gly Pro Asp Phe Thr 
1               5                   10                  15      


Leu Lys Ile Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys 
            20                  25                  30          


<210> 799
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 799
Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
1               5                   10              


<210> 800
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 800
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Pro Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Arg Gly Ser Gly Gly Asp Thr Trp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Trp Val Gly Arg Asp Ala Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210> 801
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 801
Asp Ile Gln Leu Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Leu Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asp Gly Asn Thr Tyr Leu Asn Trp Phe Gln Gln Arg Pro Gly Gln Ser 
        35                  40                  45              


Pro Arg Arg Leu Ile Tyr Lys Val Ser Asn Arg Asp Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Val Ser Gly Pro Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Gly 
                85                  90                  95      


Thr His Trp Pro Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg Thr Val 
        115 


<210> 802
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 802
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Thr Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gln Val Asp Lys Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210> 803
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 803
Asp Ile Met Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile His Asn Tyr 
            20                  25                  30          


Leu Asn Trp Ile Gln Gln Thr Pro Gly Lys Ala Pro Lys Leu Leu Val 
        35                  40                  45              


Phe Ala Ala Ser Thr Leu Gln Arg Gly Val Pro Pro Arg Tyr Ser Gly 
    50                  55                  60                  


Arg Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Thr Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Arg Arg Thr Val 
            100                 105                 110 


<210> 804
<211> 118
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 804
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Asp Asp Gly Ser Tyr Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gly Gly Tyr Ser Tyr Ser Tyr Met Ala Ile Trp Gly Lys Gly Thr 
            100                 105                 110         


Thr Val Thr Val Ser Ser 
        115             


<210> 805
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 805
Asp Ile Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Gly Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ser Tyr Phe Cys Gln Gln Thr Tyr Ser Thr Gln Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 806
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 806
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asn Asp 
            20                  25                  30          


Ile Ile His Trp Val Arg Gln Ala Pro Gly Gln Arg Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Ala Gly Tyr Gly Asn Thr Gln Tyr Ser Gln Asn Phe 
    50                  55                  60                  


Gln Asp Arg Val Ser Ile Thr Arg Asp Thr Ser Ala Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ile Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Tyr Tyr Arg Ser Pro Thr Trp Phe Asp Trp Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210> 807
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 807
Glu Thr Thr Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Gly Asp Tyr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 808
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 808
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Asp Asp Gly Ser Tyr Lys Tyr Tyr Gly Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gly Ser Gly Trp Gly Tyr Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Met Val Thr Val Ser Ser 
        115                 120 


<210> 809
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 809
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Glu Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln His Lys Pro Gly Lys Ala Pro Asn Pro Leu Val 
        35                  40                  45              


Phe Asp Ala Ala Asn Leu Glu Thr Gly Val Pro Pro Arg Phe Ser Ala 
    50                  55                  60                  


Thr Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Ser Phe Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Asp Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 810
<211> 119
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 810
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Phe Asn Ser Phe 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Gly Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Val Asp Gly Tyr Gly Ala Phe Asp Ile Trp Gly Gln Gly 
            100                 105                 110         


Thr Met Val Thr Val Ser Ser 
        115                 


<210> 811
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 811
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asn Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Arg Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Glu Ala Pro Lys Val Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr His Cys Gln Gln Thr Phe Ser Asp Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 812
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 812
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Phe Asn Ser Phe 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Gly Ser Gly Gly Gly Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Gly Trp Glu Val Arg Thr Pro Gly Tyr Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 813
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 813
Asp Val Val Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser His Arg Ile Phe Ser Tyr 
            20                  25                  30          


Leu Thr Trp Tyr His Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Ser Gly Ala Ser Ser Leu Gly Ala Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Gly Thr Tyr Tyr Cys Gln Gln Ser Phe Ser Asp Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 814
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 814
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Thr Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gly Ala Leu Asp Ile Trp Gly Gln Gly Thr Met Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210> 815
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 815
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Val Ile His Asn Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Lys Gln Lys Pro Gly Gln Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ser Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110 


<210> 816
<211> 123
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 816
Glu Val Gln Leu Val Gln Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gly Arg Gln Tyr Asp Phe Trp Ser Gly Trp Asp Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210> 817
<211> 111
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 817
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Thr Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


His Asp Ala Ser Ile Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ala 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Leu Pro 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys Arg Thr Val 
            100                 105                 110     


<210> 818
<211> 122
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 818
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Glu Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Gly Ser Gly Phe Thr Phe Arg Asp Tyr 
            20                  25                  30          


Ala Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Gly Ser Gly Gly Asn Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Glu Tyr Ser Ser Gly Trp Pro Ser Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210> 819
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 819
Glu Ile Val Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Arg Thr Val Gly Thr Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Arg Pro Gly Lys Pro Pro Gln Ala Leu Ile 
        35                  40                  45              


Leu Gly Val Ser Ile Leu Glu Gly Gly Val Ser Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ala Gly Ser Gly Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Gly Thr Tyr Tyr Cys Gln Gln Ser His Asp Val Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Asp Leu Arg Arg Thr Val 
            100                 105                 110 


<210> 820
<211> 115
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 820
Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Thr Gly Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Arg Asn Leu Asp Ser Trp Gly Gln Gly Thr Leu Val Thr 
            100                 105                 110         


Val Ser Ser 
        115 


<210> 821
<211> 110
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 821
Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile His Asn Tyr 
            20                  25                  30          


Leu Asn Trp Ile Gln Gln Thr Pro Gly Lys Ala Pro Lys Leu Leu Val 
        35                  40                  45              


Phe Ala Ala Ser Thr Leu Gln Arg Gly Val Pro Pro Arg Tyr Ser Gly 
    50                  55                  60                  


Arg Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Thr Thr Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Arg Arg Thr Val 
            100                 105                 110 


<210> 822
<211> 176
<212> PRT
<213> Homo sapiens

<400> 822
Gln Asp Lys Pro Phe Leu Ser Ala Trp Pro Gly Thr Val Val Ser Glu 
1               5                   10                  15      


Gly Gln His Val Thr Leu Gln Cys Arg Ser Arg Leu Gly Phe Asn Glu 
            20                  25                  30          


Phe Ser Leu Ser Lys Glu Asp Gly Met Pro Val Pro Glu Leu Tyr Asn 
        35                  40                  45              


Arg Ile Phe Arg Asn Ser Phe Leu Met Gly Pro Val Thr Pro Ala His 
    50                  55                  60                  


Ala Gly Thr Tyr Arg Cys Cys Ser Ser His Pro His Ser Pro Thr Gly 
65                  70                  75                  80  


Trp Ser Ala Pro Ser Asn Pro Val Val Ile Met Val Thr Gly Val His 
                85                  90                  95      


Arg Lys Pro Ser Leu Leu Ala His Pro Gly Pro Leu Val Lys Ser Gly 
            100                 105                 110         


Glu Thr Val Ile Leu Gln Cys Trp Ser Asp Val Arg Phe Glu Arg Phe 
        115                 120                 125             


Leu Leu His Arg Glu Gly Ile Thr Glu Asp Pro Leu Arg Leu Val Gly 
    130                 135                 140                 


Gln Leu His Asp Ala Gly Ser Gln Val Asn Tyr Ser Met Gly Pro Met 
145                 150                 155                 160 


Thr Pro Ala Leu Ala Gly Thr Tyr Arg Cys Phe Gly Ser Val Thr His 
                165                 170                 175     


<210> 823
<211> 180
<212> PRT
<213> Homo sapiens

<400> 823
Leu Met Gly Gly Gln Asp Lys Pro Phe Leu Ser Ala Arg Pro Ser Thr 
1               5                   10                  15      


Val Val Pro Arg Gly Gly His Val Ala Leu Gln Cys His Tyr Arg Arg 
            20                  25                  30          


Gly Phe Asn Asn Phe Met Leu Tyr Lys Glu Asp Arg Ser His Val Pro 
        35                  40                  45              


Ile Phe His Gly Arg Ile Phe Gln Glu Ser Phe Ile Met Gly Pro Val 
    50                  55                  60                  


Thr Pro Ala His Ala Gly Thr Tyr Arg Cys Arg Gly Ser Arg Pro His 
65                  70                  75                  80  


Ser Leu Thr Gly Trp Ser Ala Pro Ser Asn Pro Leu Val Ile Met Val 
                85                  90                  95      


Thr Gly Asn His Arg Lys Pro Ser Leu Leu Ala His Pro Gly Pro Leu 
            100                 105                 110         


Leu Lys Ser Gly Glu Thr Val Ile Leu Gln Cys Trp Ser Asp Val Met 
        115                 120                 125             


Phe Glu His Phe Phe Leu His Arg Glu Gly Ile Ser Glu Asp Pro Ser 
    130                 135                 140                 


Arg Leu Val Gly Gln Ile His Asp Gly Val Ser Lys Ala Asn Phe Ser 
145                 150                 155                 160 


Ile Gly Pro Leu Met Pro Val Leu Ala Gly Thr Tyr Arg Cys Tyr Gly 
                165                 170                 175     


Ser Val Pro His 
            180 


<210> 824
<211> 180
<212> PRT
<213> Homo sapiens

<400> 824
His Met Gly Gly Gln Asp Lys Pro Phe Leu Ser Ala Trp Pro Ser Ala 
1               5                   10                  15      


Val Val Pro Arg Gly Gly His Val Thr Leu Arg Cys His Tyr Arg His 
            20                  25                  30          


Arg Phe Asn Asn Phe Met Leu Tyr Lys Glu Asp Arg Ile His Ile Pro 
        35                  40                  45              


Ile Phe His Gly Arg Ile Phe Gln Glu Ser Phe Asn Met Ser Pro Val 
    50                  55                  60                  


Thr Thr Ala His Ala Gly Asn Tyr Thr Cys Arg Gly Ser His Pro His 
65                  70                  75                  80  


Ser Pro Thr Gly Trp Ser Ala Pro Ser Asn Pro Val Val Ile Met Val 
                85                  90                  95      


Thr Gly Asn His Arg Lys Pro Ser Leu Leu Ala His Pro Gly Pro Leu 
            100                 105                 110         


Val Lys Ser Gly Glu Arg Val Ile Leu Gln Cys Trp Ser Asp Ile Met 
        115                 120                 125             


Phe Glu His Phe Phe Leu His Lys Glu Gly Ile Ser Lys Asp Pro Ser 
    130                 135                 140                 


Arg Leu Val Gly Gln Ile His Asp Gly Val Ser Lys Ala Asn Phe Ser 
145                 150                 155                 160 


Ile Gly Pro Met Met Leu Ala Leu Ala Gly Thr Tyr Arg Cys Tyr Gly 
                165                 170                 175     


Ser Val Thr His 
            180 


<210> 825
<211> 85
<212> PRT
<213> Homo sapiens

<400> 825
His Glu Gly Val His Arg Lys Pro Ser Leu Leu Ala His Pro Gly Pro 
1               5                   10                  15      


Leu Val Lys Ser Glu Glu Thr Val Ile Leu Gln Cys Trp Ser Asp Val 
            20                  25                  30          


Met Phe Glu His Phe Leu Leu His Arg Glu Gly Met Phe Asn Asp Thr 
        35                  40                  45              


Leu Arg Leu Ile Gly Glu His His Asp Gly Val Ser Lys Ala Asn Phe 
    50                  55                  60                  


Ser Ile Ser Arg Met Thr Gln Asp Leu Ala Gly Thr Tyr Arg Cys Tyr 
65                  70                  75                  80  


Gly Ser Val Thr His 
                85  


<210> 826
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 826
Val Thr Tyr Ala Gln Leu 
1               5       


